<SEC-DOCUMENT>0001193125-20-183345.txt : 20200630
<SEC-HEADER>0001193125-20-183345.hdr.sgml : 20200630
<ACCEPTANCE-DATETIME>20200630075353
ACCESSION NUMBER:		0001193125-20-183345
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20200630
DATE AS OF CHANGE:		20200630

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			II-VI INC
		CENTRAL INDEX KEY:			0000820318
		STANDARD INDUSTRIAL CLASSIFICATION:	OPTICAL INSTRUMENTS & LENSES [3827]
		IRS NUMBER:				251214948
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-239549
		FILM NUMBER:		201000453

	BUSINESS ADDRESS:	
		STREET 1:		375 SAXONBURG BLVD
		CITY:			SAXONBURG
		STATE:			PA
		ZIP:			16056
		BUSINESS PHONE:		724-352-4455

	MAIL ADDRESS:	
		STREET 1:		375 SAXONBURG BLVD
		CITY:			SAXONBURG
		STATE:			PA
		ZIP:			16056
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>d32995d424b5.htm
<DESCRIPTION>424B5
<TEXT>
<HTML><HEAD>
<TITLE>424B5</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filed Pursuant to Rule 424(b)(5) <BR>Registration No. 333-239549 </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#9b4045">The information in this preliminary prospectus supplement is not
complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities and are not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not
permitted. </FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#9b4045">Subject to Completion
</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#9b4045">Dated June&nbsp;30, 2020 </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U><B>PRELIMINARY PROSPECTUS SUPPLEMENT </B> </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(To Prospectus
dated June&nbsp;30, 2020) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Shares </B></P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g32995g36b76.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:20%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:9pt; font-family:Times New Roman">We are offering
$350,000,000 of our common stock, no par value per share.&nbsp;Our common stock is listed on The Nasdaq Global Select Market under the symbol &#147;IIVI.&#148; On June&nbsp;29, 2020, the last reported sale price of our common stock on The Nasdaq
Global Select Market was $48.39 per share. Assuming an offering price of $48.39 per share, we would expect to offer 7,232,899 shares of our common stock. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:9pt; font-family:Times New Roman">Concurrently with this offering, we are offering 2,000,000 shares of our&nbsp;&nbsp;&nbsp;&nbsp;% Series A Mandatory Convertible Preferred
Stock, liquidation preference $200.00 per share (the &#147;Mandatory Convertible Preferred Stock&#148;), pursuant to a separate prospectus supplement (the &#147;Concurrent Mandatory Convertible Preferred Stock Offering&#148;). We have also granted
the underwriters of the Concurrent Mandatory Convertible Preferred Stock Offering a <FONT STYLE="white-space:nowrap">30-day</FONT> option to purchase up to an additional 300,000 shares of Mandatory Convertible Preferred Stock, solely to cover
over-allotments, if any. Neither the completion of this offering nor of the Concurrent Mandatory Convertible Preferred Stock Offering is contingent on the completion of the other, so it is possible that this offering occurs and the Concurrent
Mandatory Convertible Preferred Stock Offering does not occur, and vice versa. We cannot assure you that the Concurrent Mandatory Convertible Preferred Stock Offering will be completed on the terms described herein, or at all. The Concurrent
Mandatory Convertible Stock Offering is being made pursuant to a separate prospectus supplement, and nothing contained herein shall constitute an offer to sell or a solicitation of an offer to buy shares of Mandatory Convertible Preferred Stock. See
&#147;Concurrent Mandatory Convertible Preferred Stock Offering.&#148; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:9pt; font-family:Times New Roman">We intend to use up to $714.6 million of the net proceeds from this
offering, the Concurrent Mandatory Convertible Preferred Stock Offering and/or cash on hand to repay borrowings (including accrued interest) under our Credit Agreement (as defined herein) and to use the remainder of net proceeds, if any, to develop,
enhance, invest in or acquire related, emerging, or complementary technologies, products, or businesses and for other general corporate purposes. See &#147;Use of Proceeds.&#148; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:11pt; font-family:Times New Roman"><B>Investing in our common stock involves certain risks. See &#147;<A HREF="#supptoc32995_6">Risk Factors</A>&#148; beginning on page S-10 of
this prospectus supplement. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:9pt; font-family:Times New Roman">We have granted the underwriters the option to purchase up to an additional $52,500,000 of our common stock
from us at the public offering price less the underwriting discounts within 30&nbsp;days from the date of this prospectus supplement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:9pt; font-family:Times New Roman"><B>Neither the U.S. Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these securities or
determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense. </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:20%">&nbsp;</P></center> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85.5%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="19%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Per&nbsp;Share</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Public offering price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Underwriting discounts and commissions(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Proceeds, before expenses, to us</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">See &#147;Underwriting&#148; for a description of the compensation payable to the
underwriters.&nbsp;&nbsp;&nbsp;&nbsp; </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:9pt; font-family:Times New Roman">The underwriters expect to deliver the securities to purchasers on or about
July&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:20%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Joint
Book-Running Managers </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:18pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="36%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="28%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:18pt">
<TD VALIGN="top" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;BofA&nbsp;Securities</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>J.P.&nbsp;Morgan&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Citigroup&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:20%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>July&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020 </B></P>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Prospectus Supplement </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc32995_1">ABOUT THIS PROSPECTUS SUPPLEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc32995_2">TRADEMARKS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc32995_3">SPECIAL NOTE ABOUT FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-2</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc32995_4">SUMMARY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-5</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc32995_5">THE OFFERING</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-8</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc32995_6">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-10</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc32995_7">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-16</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc32995_8">CONCURRENT MANDATORY CONVERTIBLE PREFERRED STOCK OFFERING</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-16</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc32995_9">DIVIDEND POLICY ON COMMON STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-19</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc32995_10">CAPITALIZATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-20</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc32995_11">DESCRIPTION OF COMMON STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-22</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc32995_12">MATERIAL U.S. FEDERAL INCOME AND ESTATE TAX CONSIDERATIONS FOR <FONT
STYLE="white-space:nowrap">NON-U.S.</FONT> HOLDERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-27</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc32995_13">UNDERWRITING</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-31</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc32995_14">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-39</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc32995_15">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-39</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc32995_16">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-39</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc32995_17">INCORPORATION BY REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-40</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Prospectus </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc32717_1">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc32717_2">SPECIAL NOTE ABOUT FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc32717_3">TRADEMARKS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc32717_4">THE COMPANY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc32717_5">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc32717_6">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc32717_7">DIVIDEND POLICY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc32717_8">DESCRIPTION OF CAPITAL STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc32717_9">SELLING SECURITYHOLDERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc32717_10">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc32717_11">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc32717_12">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc32717_13">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc32717_14">INCORPORATION BY REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc32995_1"></A>ABOUT THIS PROSPECTUS SUPPLEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">This prospectus supplement and the accompanying prospectus are part of a registration statement on
<FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> that we filed with the Securities and Exchange Commission (the &#147;SEC&#148;), and that became automatically effective upon filing. This document is in two parts. The first part is this
prospectus supplement, which describes the terms of this offering of common stock and also adds, updates and changes information contained in the accompanying prospectus and the documents incorporated herein by reference. The second part is the
prospectus, which gives more general information, some of which may not apply to this offering of common stock. If the information contained in this prospectus supplement differs or varies from the information contained in the accompanying
prospectus or any document incorporated herein by reference, you should rely on the information in this prospectus supplement. Before investing in our common stock, you should read this prospectus supplement and the accompanying prospectus, as well
as the additional information incorporated by reference herein described under &#147;Incorporation by Reference&#148; on page S-40 of this prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In this prospectus supplement, the &#147;Company,&#148; &#147;we,&#148; &#147;us&#148; and &#147;our&#148; and similar terms refer to <FONT
STYLE="white-space:nowrap">II-VI</FONT> Incorporated and its subsidiaries. References to our &#147;common stock&#148; refer to the common stock of <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We have not authorized anyone to provide you with any information or to make any representation, other than those contained or incorporated by
reference in this prospectus supplement and the accompanying prospectus or in any free writing prospectus we have prepared and to which we have referred you. We take no responsibility for, and provide no assurance as to the reliability of, any other
information that others may give you. Neither we nor the underwriters are making an offer to sell or soliciting an offer to buy our securities in any jurisdiction where an offer or solicitation is not authorized or in which the person making that
offer or solicitation is not qualified to do so or to anyone to whom it is unlawful to make an offer or solicitation. You should assume that the information appearing in this prospectus supplement, the accompanying prospectus, the documents
incorporated by reference into this prospectus supplement and the accompanying prospectus, and in any free writing prospectus that we may authorize for use in connection with this offering, is accurate only as of the date of those respective
documents. Our business, financial condition, results of operations and prospects may have changed since those dates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We are offering to
sell, and seeking offers to buy, shares of common stock only in jurisdictions where offers and sales are permitted. The distribution of this prospectus supplement and the accompanying prospectus and the offering of the common stock in certain
jurisdictions may be restricted by law. Persons outside the United States who come into possession of this prospectus supplement and the accompanying prospectus must inform themselves about, and observe any restrictions relating to, the offering of
the common stock and the distribution of this prospectus supplement and the accompanying prospectus outside the United States. This prospectus supplement and the accompanying prospectus do not constitute, and may not be used in connection with, an
offer to sell, or a solicitation of an offer to buy, any securities offered by this prospectus supplement and accompanying prospectus by any person in any jurisdiction in which it is unlawful for such person to make such an offer or solicitation.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Unless otherwise stated, information in this prospectus supplement assumes no exercise of the underwriters&#146; option to purchase
additional shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc32995_2"></A>TRADEMARKS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We have proprietary rights to trademarks used in the information incorporated by reference into this prospectus supplement, which are
important to our business, many of which are registered under applicable intellectual property laws. Solely for convenience, trademarks and trade names referred to in the information incorporated by reference in this prospectus supplement may appear
without the &#147;<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>&#148; or &#147;<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP>&#148; symbols, but such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-1 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
references are not intended to indicate, in any way, that we will not assert, to the fullest extent possible under applicable law, our rights or the rights of the applicable licensor to these
trademarks and trade names. We do not intend our use or display of other companies&#146; trade names, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of us by, any other companies. Each trademark, trade name
or service mark of any other company appearing in this prospectus supplement is the property of its respective holder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc32995_3">
</A>SPECIAL NOTE ABOUT FORWARD-LOOKING STATEMENTS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Certain information set forth in this prospectus supplement, the accompanying
prospectus or the documents incorporated herein by reference may contain forward-looking statements within the meaning of Section&nbsp;27A of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), and Section&nbsp;21E of the
Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), that are intended to be covered by the &#147;safe harbor&#148; created by those sections. Forward-looking statements, which are based on certain assumptions and describe our
future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as &#147;believe,&#148; &#147;expect,&#148; &#147;may,&#148; &#147;will,&#148; &#147;should,&#148; &#147;would,&#148; &#147;could,&#148;
&#147;seek,&#148; &#147;intend,&#148; &#147;plan,&#148; &#147;estimate,&#148; &#147;goal,&#148; &#147;anticipate,&#148; &#147;project&#148; or other comparable terms. All statements other than statements of historical facts included in this
prospectus supplement, the accompanying prospectus or the documents incorporated herein by reference regarding our strategies, prospects, expectations, financial condition, operations, costs, plans and objectives are forward-looking statements.
Examples of forward-looking statements include, among others, statements we make regarding this offering and the Concurrent Mandatory Convertible Preferred Stock Offering, expected future operating results, anticipated results of our sales and
marketing efforts, and anticipated benefits resulting from completed acquisitions. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and
assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent
uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Important factors that could cause actual results, conditions and events to differ materially from those indicated in the
forward-looking statements include, among others, statements about: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">uncertainties associated with the coronavirus <FONT STYLE="white-space:nowrap">(COVID-19)</FONT> pandemic,
including its possible effects on our operations, liquidity, financial condition, supply chain and personnel, and the demand for our products and services; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the possibility that our actual operating results for the quarter ended June 30, 2020 may differ, potentially
materially, from the expected operating results for such quarter as discussed in &#147;Summary&#151;Recent Developments;&#148; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">investments in future markets of potential significant growth which may not result in the expected return;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the possibility that the anticipated benefits from completed acquisitions, including, but not limited to, our
combination with Finisar Corporation (&#147;Finisar&#148;), cannot be realized in full or at all or may take longer to realize than expected; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to develop new products and processes; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">global economic downturns, including any downturn related to <FONT STYLE="white-space:nowrap">COVID-19,</FONT>
which may adversely affect our business, operating results and financial condition; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">some systems that use our products which are complex in design, and products of ours that may contain defects
that are not detected until deployed, which could increase our costs, reduce our revenues, cause us to lose key customers and may expose us to litigation arising from derivative lawsuits related to consumer products; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-2 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">foreign currency risk which may negatively affect our revenues, cost of sales and operating margins and could
result in foreign exchange losses; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to retain our competitive position, which may require significant investments; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our inability to successfully implement our acquisitions strategy or integrate acquired companies and personnel
with existing operations; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our future success being dependent on continued international sales, and the fact that our global operations are
complex and present multiple challenges to manage; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">complex and rapidly changing governmental import and export regulations; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in U.S. trade policies, particularly with respect to China and to companies on the U.S. Entity List, such
as Huawei, could impact our international operations and the cost of goods imported into the United States, which may narrow the size of our markets, materially impact our revenues or increase our operating costs and expose us to contract
litigation; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to settle conversions of our 0.25% convertible senior notes due 2022 (the &#147;2022 notes&#148;) in
cash or to repurchase such notes in accordance with their terms; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our failure to accurately estimate the size and growth of our markets and our customers&#146; demands;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">increased competition; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">limitations on the protection of our intellectual property, and our involvement from time to time in costly
intellectual property litigation or indemnification; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a significant portion of our business being dependent on cyclical industries; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our global operations being subject to complex legal and regulatory requirements; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in laws and regulations governing data privacy and data protection that could have a material adverse
impact on our business; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">data breach incidents and breakdown of information and communication technologies that could disrupt our
operations and impact our financial results; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our entry into supply agreements which commit us to supply products on specified terms; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our dependence on highly complex manufacturing processes that require feeder materials, components and products
from limited sources of supply; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">increases in commodity prices that may adversely affect our results of operations and financial condition;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our use and generation of potentially hazardous substances that are subject to stringent environmental
regulations; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">unfavorable changes in tax rates, tax liabilities or tax accounting rules that could negatively affect future
results; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">natural disasters or other global or regional catastrophic events that could disrupt our operations, give rise to
substantial environmental hazards and adversely affect our results; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-3 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to attract, retain and develop key personnel and need for continued good relations with our
employees; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our stock price, which has been volatile in the past and may be volatile in the future; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">some anti-takeover provisions contained in our Amended and Restated Articles of Incorporation (the &#147;Articles
of Incorporation&#148;) and Amended and Restated By-Laws (the &#147;By-Laws&#148;), as well as provisions of Pennsylvania law, which could impair a takeover attempt and also reduce the market price of our common stock; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">because we do not currently intend to pay dividends, holders of our common stock will benefit from an investment
in our common stock only if it appreciates in value, and by the intended anti-dilution actions of our share-buyback program; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our contracts with a number of large <FONT STYLE="white-space:nowrap">end-user</FONT> service providers and
product companies that have considerable bargaining power, which may require us to agree to terms and conditions that could have an adverse effect on our business or ability to recognize revenues; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">climate change regulations; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our dependence on large purchases from a few significant customers, and any loss, cancellation, reduction or
delay in purchases by these customers which could harm our business; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the manufacturing of our products which may be adversely affected if we are unable to manufacture certain
products in our manufacturing facilities; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our failure to accurately forecast our revenues which could result in additional charges for obsolete or excess
inventories or <FONT STYLE="white-space:nowrap">non-cancelable</FONT> purchase commitments; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our failure to maintain an effective system of disclosure controls and internal control over financial reporting,
which could impair our ability to produce timely and accurate financial statements or comply with applicable regulations; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">those risks and uncertainties included in this prospectus supplement under the caption &#147;Risk Factors;&#148;
and </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">those risks and uncertainties described in the documents incorporated by reference into this prospectus
supplement. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Therefore, you should not rely on any of our forward-looking statements. We urge you to consider the risks
and uncertainties described and incorporated by reference herein in evaluating our forward-looking statements. All subsequent written and oral forward-looking statements attributable to us or to persons acting on our behalf are expressly qualified
in their entirety by the applicable cautionary statements. We further caution readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Except as otherwise required by the federal securities
laws, we undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-4 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc32995_4"></A>SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This summary highlights selected information contained elsewhere, or incorporated by reference, in this prospectus supplement. This summary does not
contain all of the information that you should consider before deciding to invest in our securities. You should carefully read this prospectus supplement, the accompanying prospectus and the documents incorporated by reference herein, including the
risks of investing in our securities discussed under the heading &#147;Risk Factors&#148; contained herein and in the accompanying prospectus, and under a similar heading in other documents that are incorporated by reference into this prospectus
supplement. You also should carefully read the information incorporated by reference into this prospectus supplement, including our financial statements and the exhibits to the registration statement of which this prospectus supplement is a part.
Unless otherwise indicated, &#147;common stock&#148; means our common stock, offered by this prospectus supplement. Unless the context otherwise requires, <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated is referred to herein, collectively
with all of its subsidiaries, as the &#147;Company,&#148; <FONT STYLE="white-space:nowrap">&#147;II-VI,&#148;</FONT> or &#147;we,&#148; &#147;us,&#148; or &#147;our.&#148; </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Overview </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">II-VI</FONT> Incorporated, a worldwide leader in engineered materials and optoelectronic components, is a vertically integrated manufacturing company that develops innovative products for industrial materials processing,
communications, aerospace and defense, consumer electronics, semiconductor capital equipment, life sciences and automotive end markets. On September&nbsp;24, 2019, we completed our acquisition of Finisar, a global technology leader for subsystems
and components for fiber optic communications. We believe that our combination with Finisar will help make us a global leader in optical communications while continuing our leadership in other end markets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We develop, manufacture, and market engineered materials, optoelectronic components, and devices for precision use in industrial materials
processing, optical communications, aerospace and defense, consumer electronics, semiconductor capital equipment, life sciences, and automotive applications and markets. We use advanced engineered materials growth technologies coupled with
proprietary high-precision fabrication, microassembly, optical thin-film coating, and electronic integration to manufacture complex optoelectronic devices and modules. Our products are deployed in a variety of applications, including (i)&nbsp;laser
cutting, welding, and marking operations; (ii) 3D sensing consumer applications; (iii)&nbsp;optical, data, and wireless communications products; (iv)&nbsp;strategic aerospace and defense applications including intelligence, surveillance, and
reconnaissance; (v)&nbsp;semiconductor processing and tooling; and (vi)&nbsp;thermoelectric cooling and power-generation solutions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Through research, development and engineering (RD&amp;E) and acquisitions, we have expanded our portfolio of materials. We believe that the
materials we grow and fabricate are differentiated by one or a combination of unique optical, electrical, thermal, and mechanical properties. Our optics are shaped by precision surfacing techniques to meet the most stringent requirements for flat or
curved geometries, functionalized with smooth or structured surfaces, or with patterned metallization. Proprietary processes developed at our global optical coating centers differentiate our products&#146; durability against high-energy lasers and
extreme operating environments. Optical coatings also provide the desired spectral characteristics ranging from the ultraviolet to the <FONT STYLE="white-space:nowrap">far-infrared.</FONT> We leverage these capabilities to deliver miniature- to
large-scale precision optical assemblies, including those in combination with thermal management components, integrated electronics, and/or software. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We also offer a broad portfolio of compound semiconductor lasers that are used in a variety of applications in most of our end markets. These
compound semiconductor lasers enable high-power lasers for materials processing; optical signal amplification in terrestrial and submarine communications networks;
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">high-bit-rate</FONT></FONT> server connectivity between and within datacenters; and fast and accurate measurements in biomedical instruments, consumer electronics, and optical
communications network monitoring. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">S-5</FONT> </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We generate revenues, earnings and cash flows from developing, manufacturing and marketing a
broad portfolio of products for our end markets. We also generate revenue, earnings and cash flows from government-funded research and development contracts relating to the development and manufacture of new technologies, materials and products.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our customer base includes original equipment manufacturers, laser end users, system integrators of high-power lasers, manufacturers of
equipment and devices for industrial, optical communications, consumer electronics, security and monitoring applications, U.S. government prime contractors, and various U.S. government agencies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We are headquartered in Saxonburg, Pennsylvania, with RD&amp;E, manufacturing, and sales facilities worldwide. Our U.S. production and
research and development operations are located in Pennsylvania, California, New Jersey, Texas, Mississippi, Massachusetts, Connecticut, Delaware, New York, Florida, Ohio, Arizona, Colorado, and Illinois, and our
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> production operations are based in China, Singapore, Vietnam, the Philippines, Germany, Switzerland, and the United Kingdom. We also utilize contract manufacturers and strategic suppliers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recent Developments </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Outlook for Three Months Ending
June 30, 2020 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Based on management estimates and the assumptions described herein, we expect to report revenue for the quarter ending
June 30, 2020 in the range of $710 to $740 million. In addition, we expect to report an operating income margin (prepared in accordance with U.S. generally accepted accounting principles) in the range of 9% to 11%. While revenue in the quarter has
grown significantly beyond our prior expectations in the quarter, customers often make purchasing decisions through the last day of the quarter that could cause our final revenue for the quarter to differ materially, both positively or negatively,
from our current projection. These decisions may include retiming of deliveries to occur beyond quarter end, determinations to draw or not draw from consigned inventory in the last few days of the quarter, or other factors that are solely in the
customers&#146; discretion. Operating income margin is also subject to change for a variety of reasons, including the effect of exchange gains or losses, factors that impact operating efficiency, performance-based employee compensation, and
refinement of purchase accounting, among other factors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The foregoing projected revenue and operating income ranges for the fourth
quarter of fiscal 2020 are preliminary, unaudited and subject to completion. We have provided a range, rather than a specific amount, because our financial closing and review procedures for the quarter ending June 30, 2020 have yet to be performed.
The forecasted information reflects management&#146;s current views and may change as a result of management&#146;s review of results and other factors, including a variety of significant business, economic and competitive risks and uncertainties.
Please see the section entitled &#147;Risk Factors&#148; included in this prospectus supplement and our filings with the SEC that are incorporated by reference herein for more information. The forecasted information is subject to change following
the closing of our fourth quarter of 2020 financial results and finalization of quarter- and fiscal-year end financial and accounting procedures (which have yet to be performed) and should not be viewed as a substitute for full financial statements
prepared in accordance with U.S. generally accepted accounting principles. Our independent registered public accounting firm has not audited, reviewed, compiled or performed any procedures, and does not express an opinion or any other form of
assurance, with respect to the forecasted information. We do not expect to disclose publicly whether our expectations have changed or to update our expectations, other than through the release of actual results in the ordinary course of business.
Actual results may vary materially. Accordingly, you should not place undue reliance on our projections with respect to the fourth quarter of fiscal 2020 set forth above. The above disclosures and projections constitute forward-looking statements
and should be read together with the financial information included in our periodic reports incorporated by reference into this prospectus supplement. See &#147;Cautionary Note on Forward-Looking Statements&#148; in this prospectus supplement for
more information. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">S-6</FONT> </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Company Information </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We were incorporated in the Commonwealth of Pennsylvania on June&nbsp;22, 1971. Our corporate headquarters are located at 375 Saxonburg
Boulevard, Saxonburg, Pennsylvania 16056. Our telephone number is (724) <FONT STYLE="white-space:nowrap">352-4455.</FONT> Our Internet website address is <FONT STYLE="white-space:nowrap">www.ii-vi.com.</FONT> The information contained on, or that
can be accessed through, our website is deemed not to be incorporated in this prospectus supplement or to be part of this prospectus supplement. Our name is pronounced &#147;Two Six Incorporated,&#148; which refers to Groups II and VI on the
periodic table of elements from which we originally designed and produced infrared optics for high-power carbon dioxide lasers used in materials processing. You can obtain additional information regarding our business by reading our Annual Report on
Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended June&nbsp;30, 2019, our Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for fiscal 2020 and the other reports we file with the SEC that are
incorporated by reference herein. See &#147;Where You Can Find More Information.&#148; </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">S-7</FONT> </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc32995_5"></A>THE OFFERING </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Common stock offered</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Common stock to be outstanding after this offering</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock (or &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares if the underwriters&#146; option to purchase
additional shares of common stock is exercised in full).</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Option to purchase additional shares of common stock</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">We will grant the underwriters the right to purchase, within a period of 30 days beginning on the date of this prospectus supplement, up to an additional
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Concurrent Mandatory Convertible Preferred Stock Offering</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Concurrently with this offering of our common stock, we are offering 2,000,000 shares of our &nbsp;&nbsp;&nbsp;&nbsp;% Series A Mandatory Convertible Preferred Stock, liquidation preference $200.00 per share (the &#147;Mandatory
Convertible Preferred Stock&#148;) (or 2,300,000 shares if the underwriters of such offering exercise in full their over-allotment option to purchase additional shares of Mandatory Convertible Preferred Stock) (the &#147;Concurrent Mandatory
Convertible Preferred Stock Offering&#148;) in an underwritten offering pursuant to a separate prospectus supplement. Neither the completion of this offering nor of the Concurrent Mandatory Convertible Preferred Stock Offering is contingent on the
completion of the other, so it is possible that this offering occurs and the Concurrent Mandatory Convertible Preferred Stock Offering does not occur, and vice versa. We cannot assure you that the Concurrent Mandatory Convertible Preferred Stock
will be completed on the terms described herein, or at all. This prospectus supplement is not an offer to sell or a solicitation of an offer to buy any securities being offered in the Concurrent Mandatory Convertible Preferred Stock Offering. See
&#147;Concurrent Mandatory Convertible Preferred Stock Offering.&#148;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Use of proceeds</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We estimate that the net proceeds from this offering will be approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million (or $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million if the underwriters exercise their option to purchase additional
shares in full), after deducting fees and estimated offering expenses payable by us.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">We expect to use up to $714.6&nbsp;million of the net proceeds from this offering, the Concurrent Mandatory Convertible Preferred Stock Offering and/or cash on
hand to repay borrowings (including accrued interest) under the Credit Agreement and to use the remainder of net proceeds, if any, to develop, enhance, invest in or acquire related, emerging or complementary technologies, products, or businesses and
for other general corporate purposes. See &#147;Use of Proceeds.&#148;</P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">S-8</FONT> </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exchange listing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Our common stock is listed on The Nasdaq Global Select Market under the symbol &#147;IIVI.&#148;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Risk factors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">You should read the &#147;Risk Factors&#148; section of this prospectus supplement and the corresponding sections of the accompanying prospectus, our 2019 Annual Report, and our quarterly reports filed on Form <FONT
STYLE="white-space:nowrap">10-Q,</FONT> which are incorporated by reference in this prospectus supplement and the accompanying prospectus, for a discussion of certain of the factors to consider carefully before deciding to purchase any shares of our
common stock.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated, all applicable share, per share and related information in this prospectus
supplement is based on 91,175,715 shares of common stock outstanding as of March&nbsp;31, 2020, and includes 52,378&nbsp;shares held by directors, officers and employees that are subject to restricted shares, but excludes, in each case as of such
date: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">4,178,069 shares subject to outstanding stock options at a weighted average exercise price of $26.04 per share;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">3,477,231 shares subject to outstanding unvested restricted share unit awards as of March&nbsp;31, 2020;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">409,246 shares subject to outstanding performance share unit awards as of March&nbsp;31, 2020;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">3,176,426 additional shares of common stock reserved for issuance under our equity incentive plans;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">13,102,618 shares of common stock held in treasury; and </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any shares issuable upon conversion of our outstanding 2022 notes, Finisar&#146;s 0.50% Convertible Senior Notes
due 2036 (the &#147;Finisar convertible notes&#148;) and any shares of Mandatory Convertible Preferred Stock that may be issued in the Concurrent Mandatory Convertible Preferred Stock Offering. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated, all information in this prospectus supplement assumes no exercise of the underwriters&#146; option to purchase
additional shares. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">S-9</FONT> </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc32995_6"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>Investing in our common stock involves risks. In considering whether you should invest in our common stock, you should consider all of the
information we have included or incorporated by reference in this prospectus supplement and the accompanying prospectus. In particular, you should carefully consider the risk factors described below, as well as in our Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended June&nbsp;30, 2019 under &#147;Item 1A. Risk Factors&#148; and our subsequently filed Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> under &#147;Part II. Other
Information, Item 1A. Risk Factors.&#148; You should also read all other information contained in or incorporated by reference in this prospectus supplement and the accompanying prospectus before deciding to invest in our common stock. If any of the
risks actually occur, they may materially harm our business, financial condition, operating results or cash flow. As a result, the market price for our common stock could decline, and you could lose all or part of your investment. Additional risks
and uncertainties that are not yet identified or that we think are immaterial may also materially harm our business, financial condition, operating results, or cash flow and could result in a complete or partial loss of your investment. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>This prospectus supplement, the accompanying prospectus and the incorporated documents also contain forward-looking statements that involve
risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors, including the risks faced by us as described in this prospectus supplement and the
documents incorporated by reference in this prospectus supplement and the accompanying prospectus. For more information see &#147;Forward-Looking Statements&#148; in this prospectus supplement. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Relating to this Offering and our Common Stock </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The market price of our common stock has, and is likely to continue to, fluctuate significantly. This volatility may affect the price at which you are
able to sell any shares of common stock you purchase in this offering. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The market price of our common stock has been, and is
likely to continue to be, volatile, which means that it could decline substantially within a short period of time. The market price for our common stock on The Nasdaq Global Select Market varied between a high of $51.90 and a low of $19.00 in the <FONT
STYLE="white-space:nowrap">12-month</FONT> period ended June&nbsp;29, 2020. The market price of our common stock could fluctuate significantly for many reasons, including the following: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">future announcements concerning us or our competitors; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the overall performance of equity markets; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the trading volume of our common stock; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">additions or changes to our board of directors, management or key personnel; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulatory developments (including, but not limited to, developments in international trade policy, particularly
with respect to China and to companies on the U.S. Entity List, such as Huawei) and enforcement actions bearing on manufacturing, development, marketing or sales; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the commencement or outcome of litigation; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reports and recommendations of analysts and whether or not we meet the milestones, metrics and other expectations
set forth in such reports; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">gaining or losing large customers; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-10 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">introduction of new products or services and market acceptance of such products or services;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic on the business, financial condition,
results of operations or prospects of ourselves, our customers and our suppliers; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">acquisition or loss of significant manufacturers, distributors or suppliers or an inability to obtain sufficient
quantities of materials needed to provide our services; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">issuance of common stock or other securities (including, without limitation, the shares of common stock offered
hereby, the shares issued upon conversion of any shares of Mandatory Convertible Preferred Stock issued in the Concurrent Mandatory Convertible Preferred Stock Offering, and the shares issued upon conversion of our outstanding 2022 notes and Finisar
convertible notes); </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">incurrence of indebtedness; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">quarterly variations in operating results; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to accurately forecast future performance; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">business acquisitions or divestitures; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">fluctuations in the economy, political events or general market conditions; and </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in our operating industry generally. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As a result, the current market price of our common stock may not be indicative of future market prices, and we may be unable to sustain or
increase the value of an investment in our common stock. In addition, stock markets have experienced extreme price and volume fluctuations in recent years, and are experiencing exceptional volatility as a result of the effects of the <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic. Moreover, these fluctuations frequently have been unrelated to the operating performance of the affected companies. These broad market fluctuations may adversely affect the market price of our
common stock. The market price of our common stock could decline below its current price and the market price of our shares may fluctuate significantly in the future. These fluctuations may be unrelated to our performance and could be out of our
control, and could lead to securities class action litigation, which could result in substantial expenses and diversion of management&#146;s attention and corporate resources, any or all of which could adversely affect our business, financial
condition and results of operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our management team may invest or spend the proceeds of this offering or the Concurrent Mandatory Convertible
Preferred Stock Offering, if completed, in ways with which you may not agree or in ways which may not yield a significant return. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We expect to receive net proceeds of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million
from this offering, after deducting underwriting discounts and commissions and estimated offering expenses payable by us. Our management will have broad discretion over the use of proceeds from this offering and the Concurrent Mandatory Convertible
Preferred Stock Offering, if completed. We expect to use the net proceeds from this offering, the Concurrent Mandatory Convertible Preferred Stock Offering and/or cash on hand to repay
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million in borrowings (including accrued interest) under our amended and restated credit agreement, dated as of September&nbsp;24, 2019 (the
&#147;Credit Agreement&#148;), by and among the Company, Bank of America, N.A., as Administrative Agent, Swing Line Lender and an L/C Issuer, and the other lenders party thereto) and to use the remainder of net proceeds, if any, to develop, enhance,
invest in or acquire related, emerging or complementary technologies, products, or businesses and for other general corporate purposes. Our management will have considerable discretion in the application of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-11 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such net proceeds, and you will not have the opportunity, as part of your investment decision, to assess whether the proceeds are being used in ways with which you would agree. The net proceeds
may be used for corporate purposes that do not increase our operating results or enhance the value of our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The Concurrent Mandatory
Convertible Preferred Stock Offering and future sales or other dilution of our equity could dilute our existing shareholders or otherwise depress the market price of our common stock. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Concurrently with this offering, we are offering, by means of a separate prospectus supplement, 2,000,000 shares of our Mandatory Convertible
Preferred Stock and up to 300,000 additional shares of Mandatory Convertible Preferred Stock that the underwriters in the Concurrent Mandatory Convertible Preferred Stock Offering have the option, exercisable within 30 days from the date of the
prospectus supplement for the Concurrent Mandatory Convertible Preferred Stock Offering, to purchase from us, solely to cover over-allotments, if any. Neither the completion of this offering nor of the Concurrent Mandatory Convertible Preferred
Stock Offering is contingent on the completion of the other, so it is possible that this offering occurs and the Concurrent Mandatory Convertible Preferred Stock Offering does not occur, and vice versa. We cannot assure you that the Concurrent
Mandatory Convertible Preferred Stock Offering will be completed on the terms described herein, or at all. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Concurrent Mandatory
Convertible Preferred Stock Offering and future sales of our common stock in the public market, or the perception that such sales could occur, could negatively impact the market price of our common stock. We also have several institutional
shareholders that own significant blocks of our common stock. If one or more of these shareholders were to sell large portions of their holdings in a relatively short time, for liquidity or other reasons, the prevailing market price of our common
stock could be negatively affected. If we issue additional shares of common stock, the price of our common stock may decline. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Under
certain circumstances, shares of our common stock to be issued upon conversion of our Mandatory Convertible Preferred Stock that may be issued in the Concurrent Mandatory Convertible Preferred Stock Offering or that could be issued upon the
conversion of the 2022 notes or the Finisar convertible notes would dilute the ownership interest of our existing shareholders. We also issued approximately 26.7&nbsp;million shares of our common stock in connection with the Finisar acquisition. In
addition, the issuance of additional common stock, or issuances of securities convertible into or exercisable for our common stock or other equity linked securities, including preferred stock or warrants, would dilute the ownership interest of our
common shareholders and could depress the market price of our common stock and impair our ability to raise capital through the sale of additional equity securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Any sales in the public market of any shares of our common stock issuable upon conversion of the securities convertible into or exercisable
for our common stock or other equity linked securities, including shares of the Mandatory Convertible Preferred Stock, the 2022 notes, and Finisar convertible notes, could adversely affect the prevailing market price of our common stock. In
addition, the existence of the any of the Mandatory Convertible Preferred Stock, the 2022 notes, and the Finisar convertible notes may encourage short selling by market participants because the conversion of any of them could be used to satisfy
short positions, or anticipated conversion of any of them into shares of our common stock could depress the price of our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As
of March&nbsp;31, 2020, we had outstanding approximately 91,175,715 shares of our common stock and options to purchase approximately 4,178,069 shares of our common stock (of which approximately 2,634,392 were exercisable as of that date). We also
had outstanding approximately 3,886,477 shares of our common stock issuable pursuant to unvested restricted share unit awards and performance share unit awards. The sale or the availability for sale of a large number of shares of our common stock in
the public market could cause the market price of our common stock to decline. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-12 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The Mandatory Convertible Preferred Stock may adversely affect the market price of our common stock.
</I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The market price of our common stock is likely to be influenced by the Mandatory Convertible Preferred Stock, if and when issued.
For example, the market price of our common stock could become more volatile and could be depressed by: (i)&nbsp;investors&#146; anticipation of the potential resale in the market of a substantial number of additional shares of our common stock
received upon conversion of the Mandatory Convertible Preferred Stock; (ii)&nbsp;possible sales of our common stock by investors who view the Mandatory Convertible Preferred Stock as a more attractive means of equity participation in us than owning
shares of our common stock; and (iii)&nbsp;hedging or arbitrage trading activity that may develop involving the Mandatory Convertible Preferred Stock and our common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Provisions in our Amended and Restated Articles of Incorporation (the &#147;Articles of Incorporation&#148;) and Amended and Restated By-Laws (the
&#147;By-Laws&#148;) and the Pennsylvania Business Corporation Law (the &#147;BCL&#148;) may delay or prevent our acquisition by a third party. Additionally, certain rights of the holders of the Mandatory Convertible Preferred Stock could delay or
prevent our acquisition </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our Articles of Incorporation and By-Laws contain provisions that could make us a less attractive target
for a hostile takeover and could make more difficult or discourage a merger proposal, a tender offer or a proxy contest. Such provisions include: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a requirement that shareholder-nominated director nominees be nominated in advance of the meeting at which
directors are elected and that specific information be provided in connection with such nomination; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability of our board of directors to issue additional shares of common stock or preferred stock without
shareholder approval; and </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain provisions requiring supermajority approval (at least <FONT STYLE="white-space:nowrap">two-thirds</FONT>
of the votes cast by all shareholders entitled to vote thereon, voting together as a single class). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In addition, the
BCL contains provisions that may have the effect of delaying or preventing a change in control of us or changes in our management. Many of these provisions are triggered if any person or group acquires, or discloses an intent to acquire, 20% or more
of a corporation&#146;s voting power, subject to certain exceptions. These provisions: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provide the other shareholders of the corporation with certain rights against the acquiring group or person;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prohibit the corporation from engaging in a broad range of business combinations with the acquiring group or
person; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">restrict the voting and other rights of the acquiring group or person; and </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provide that certain profits realized by the acquiring group or person from the sale of our equity securities
belong to and are recoverable by us. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Regardless of the amount of a person&#146;s holdings, if a shareholder or
shareholder group (including affiliated persons) would be a party to certain proposed transactions with us or would be treated differently from other shareholders of ours in certain proposed transactions, the BCL requires approval by a majority of
votes entitled to be cast by all shareholders other than the interested shareholder or affiliate group, unless the transaction is approved by independent directors or other criteria are satisfied. Furthermore, under the BCL, a &#147;short-form&#148;
merger of <FONT STYLE="white-space:nowrap">II-VI</FONT> cannot be implemented without the consent of our board of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In addition,
as permitted by Pennsylvania law, an amendment to our Articles of Incorporation or other corporate action that is approved by shareholders may provide mandatory special treatment for specified groups of nonconsenting shareholders of the same class.
For example, an amendment to our Articles of Incorporation or other corporate action may provide that shares of common stock held by designated shareholders of record must be cashed out at a price determined by the corporation, subject to applicable
dissenters&#146; rights. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-13 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Furthermore, the BCL provides that directors may, in discharging their duties, consider, to the
extent they deem appropriate, the effects of any action upon shareholders, employees, suppliers, customers and the communities in which its offices are located. Directors are not required to consider the interests of shareholders to a greater degree
than other constituencies&#146; interests. The BCL expressly provides that directors do not violate their fiduciary duties solely by relying on &#147;poison pills&#148; or the anti-takeover provisions of the BCL. We do not currently have a
&#147;poison pill.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">All of these provisions may limit the price that investors may be willing to pay for shares of our common stock.
See &#147;Description of Common Stock&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In addition, certain rights of the holders of the Mandatory Convertible Preferred Stock
could make it more difficult or more expensive for a third party to acquire us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">For example, if a fundamental change were to occur on or
prior to July&nbsp;1, 2023, holders of the Mandatory Convertible Preferred Stock may have the right to convert their Mandatory Convertible Preferred Stock, in whole or in part, at an increased conversion rate and will also be entitled to receive a
make-whole amount equal to the present value of all remaining dividend payments on their Mandatory Convertible Preferred Stock as described in the applicable Statement with Respect to Shares governing the Mandatory Convertible Preferred Stock. These
features of the Mandatory Convertible Preferred Stock could increase the cost of acquiring us or otherwise discourage a third party from acquiring us or removing incumbent management. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our common stock is subordinate to our existing and future indebtedness, the Mandatory Convertible Preferred Stock, when issued, and any other preferred
stock we may issue in the future. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Shares of our common stock are equity interests that will rank junior to all indebtedness and
other <FONT STYLE="white-space:nowrap">non-equity</FONT> claims on us with respect to assets available to satisfy our claims, including in a liquidation of the Company. Additionally, holders of our common stock may be subject to prior dividend and
liquidation rights of any holders of our preferred stock or depositary shares representing such preferred stock then outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our
common stock will rank junior to our Mandatory Convertible Preferred Stock, when issued, with respect to the payment of dividends and amounts payable in the event of our liquidation, dissolution or <FONT STYLE="white-space:nowrap">winding-up</FONT>
of our affairs. This means that, unless accumulated dividends have been paid on all our Mandatory Convertible Preferred Stock then outstanding through the most recently completed dividend period, no dividends may be declared or paid on our common
stock and we will not be permitted to repurchase any of our common stock, subject to limited exceptions. Likewise, in the event of our voluntary or involuntary liquidation, dissolution or <FONT STYLE="white-space:nowrap">winding-up</FONT> of our
affairs, no distribution of our assets may be made to holders of our common stock until we have paid to holders of our Mandatory Convertible Preferred Stock then outstanding a liquidation preference equal to $200.00 per share plus accumulated and
unpaid dividends. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our Articles of Incorporation authorize our board of directors to issue one or more additional series of preferred
stock and set the terms of the preferred stock without seeking any further approval from our shareholders. Any preferred stock that is issued will rank ahead of our common stock in terms of dividends and liquidation rights. If we issue additional
preferred stock, it may adversely affect the market price of our common stock. Our board of directors also has the power, without shareholder approval, subject to applicable law, to set the terms of any such series of preferred stock that may be
issued, including voting rights, dividend rights and preferences over our common stock with respect to dividends or upon our dissolution, <FONT STYLE="white-space:nowrap">winding-up</FONT> and liquidation and other terms. If we issue additional
preferred stock in the future that has a preference over our common stock with respect to the payment of dividends or upon our liquidation, dissolution, or winding up, or if we issue additional preferred stock with voting rights that dilute the
voting power of our common stock, the rights of holders of our common stock or the market price of our common stock could be adversely affected. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-14 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The Mandatory Convertible Preferred Stock may adversely affect the market price of our common stock.
</I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The market price of our common stock is likely to be influenced by the Mandatory Convertible Preferred Stock. For example, the
market price of our common stock could become more volatile and could be depressed by: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">investors&#146; anticipation of the potential resale in the market of a substantial number of additional shares
of our common stock received upon conversion of the Mandatory Convertible Preferred Stock; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">possible sales of our common stock by investors who view the Mandatory Convertible Preferred Stock as a more
attractive means of equity participation in us than owning our common stock; and </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">hedging or arbitrage trading activity that we expect to develop involving the Mandatory Convertible Preferred
Stock and our common stock. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Reports published by securities or industry analysts, including projections in those reports that
exceed our actual results, could adversely affect our share price and trading volume. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Research analysts publish their own
quarterly projections regarding our operating results. These projections may vary widely from one another and may not accurately predict the results we actually achieve. Our share price may decline if we fail to meet securities research
analysts&#146; projections. Similarly, if one or more of the analysts who covers us changes its recommendation regarding our common stock or publishes inaccurate or unfavorable research about our business, our share price could decline. If one or
more of these analysts ceases coverage of us or fails to publish reports on us regularly, our share price or trading volume could decline. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Because
we do not currently intend to pay dividends, holders of our common stock will benefit from an investment in our common stock only if it appreciates in value. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We have never declared or paid any dividends on our common stock, and do not expect to pay cash dividends in the foreseeable future. We
currently anticipate that we will retain any future earnings to support operations and to finance the development of our business. As a result, the success of an investment in our common stock will depend entirely upon future appreciation in its
value. There is no guarantee that our common stock will maintain its value or appreciate in value. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>This offering is not contingent on the
consummation of the Concurrent Mandatory Convertible Preferred Stock Offering and vice versa. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The completion of this offering and
the consummation of the Concurrent Mandatory Convertible Preferred Stock Offering are not contingent upon the other, so it is possible that this offering occurs and the Concurrent Mandatory Convertible Preferred Stock Offering does not occur, and
vice versa. We cannot assure you that the Concurrent Mandatory Convertible Preferred Stock Offering will be completed on the terms described herein, if at all. Accordingly, if you decide to purchase shares of our common stock in this offering, you
should be willing to do so whether or not we complete the Concurrent Mandatory Convertible Preferred Stock Offering. This prospectus supplement is not an offer to sell or a solicitation of an offer to buy any of the shares of Mandatory Convertible
Preferred Stock being offered in the Concurrent Mandatory Convertible Preferred Stock Offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our board of directors can issue, without approval
of the holders of our common stock, preferred stock with voting and conversion rights that could adversely affect the voting power of the holders of our common stock. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our board of directors can issue, without approval of the holders of our common stock, preferred stock with voting and conversion rights that
could adversely affect the voting power of the holders of our common stock and reduce the likelihood that such holders will receive dividend payments. Such issuance could have the effect of decreasing the market price of our common stock. The
issuance of preferred stock or even the ability to issue preferred stock could also have the effect of delaying, deterring or preventing a change of control or other corporate action. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-15 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc32995_7"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We estimate that the net proceeds from the sale of shares of common stock that we are offering will be approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million (or $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million if the underwriters exercise their
option to purchase additional shares in full), after deducting the underwriting discounts and commissions and estimated offering expenses payable by us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In addition, concurrently with this offering, we are offering 2,000,000 shares of our&nbsp;&nbsp;&nbsp;&nbsp;% Series A Mandatory Convertible
Preferred Stock, liquidation preference $200.00 per share (the &#147;Mandatory Convertible Preferred Stock&#148;) (or 2,300,000 shares if the underwriters of such offering exercise in full their over-allotment option to purchase additional shares of
Mandatory Convertible Preferred Stock) in an underwritten offering pursuant to a separate prospectus supplement (the &#147;Concurrent Mandatory Convertible Preferred Stock Offering&#148;). We estimate that the net proceeds to us from the Concurrent
Mandatory Convertible Preferred Stock Offering, if completed, after deducting underwriting discounts and commissions and estimated expenses payable by us, will be approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million (or approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million if the underwriters
in the Concurrent Mandatory Convertible Preferred Stock Offering exercise in full their over-allotment option to purchase additional shares of Mandatory Convertible Preferred Stock). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We expect to use up to $714.6&nbsp;million of the net proceeds from this offering, the Concurrent Mandatory Convertible Preferred Stock
Offering and/or cash on hand to repay borrowings (including accrued interest) under the Credit Agreement and to use the remainder of net proceeds, if any, to develop, enhance, invest in, or acquire related, emerging or complementary technologies,
products, or businesses and for other general corporate purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As of March&nbsp;31, 2020, approximately $2.0&nbsp;billion of
indebtedness was outstanding under the Credit Agreement. We used these funds for working capital purposes and to finance our acquisition of Finisar, which was completed in September 2019. Indebtedness under the Credit Agreement bears interest at a
rate per annum equal to an applicable margin over a eurocurrency rate or an applicable margin over a base rate determined by reference to the highest of (a)&nbsp;the federal funds rate plus 0.50%, (b) Bank of America, N.A.&#146;s prime rate and
(c)&nbsp;a eurocurrency rate plus 1.00%. The applicable margin ranges from 1.375% to 2.25% for eurocurrency rate loans and letter of credit fees and 0.375% to 1.25% for base rate loans, in each case based on our Consolidated Total Net Leverage Ratio
(as defined in the Credit Agreement). As of March&nbsp;31, 2020, the weighted average interest rate under the Credit Agreement was 3.52%. The Credit Agreement has a maturity date of September&nbsp;24, 2024. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc32995_8"></A>CONCURRENT MANDATORY CONVERTIBLE PREFERRED STOCK OFFERING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Concurrently with this offering, we are offering 2,000,000 shares of our&nbsp;&nbsp;&nbsp;&nbsp;% Series A Mandatory Convertible Preferred
Stock, liquidation preference $200.00 per share (the &#147;Mandatory Convertible Preferred Stock&#148;) (or 2,300,000 shares if the underwriters of such offering exercise in full their over-allotment option to purchase additional shares of Mandatory
Convertible Preferred Stock), in an underwritten offering pursuant to a separate prospectus supplement (the &#147;Concurrent Mandatory Convertible Preferred Stock Offering&#148;). Neither the completion of this offering nor of the Concurrent
Mandatory Convertible Preferred Stock Offering is contingent on the completion of the other, so it is possible that this offering occurs and the Concurrent Mandatory Convertible Preferred Stock Offering does not occur, and vice versa. We cannot
assure you that the Concurrent Mandatory Convertible Preferred Stock Offering will be completed on the terms described herein, or at all. This prospectus supplement does not constitute an offer to sell or a solicitation of an offer to buy any
securities being offered in the Concurrent Mandatory Convertible Preferred Stock Offering. Certain of the underwriters in this offering are also the underwriters in the Concurrent Mandatory Convertible Preferred Stock Offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The shares of Mandatory Convertible Preferred Stock will initially be convertible into an aggregate of up
to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock (or up to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock, if the underwriters in that offering exercise their
over-allotment option in full), in each case subject to anti-dilution, make-whole and other </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-16 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
adjustments, as described in the prospectus supplement related to the offering of our shares of Mandatory Convertible Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Unless converted or redeemed earlier in accordance with the terms of the statement with respect to shares establishing the terms of the
Mandatory Convertible Preferred Stock, each share of Mandatory Convertible Preferred Stock will convert automatically on the mandatory conversion date, which is expected to be July&nbsp;1, 2023, into
between&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock, subject to certain
anti-dilution and other adjustments. The number of shares of common stock issuable upon conversion will be determined based on the average volume weighted average price per share of common stock over the 20 consecutive trading day period beginning
on, and including, the 21st scheduled trading day immediately prior to July&nbsp;1, 2023. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Dividends on the Mandatory Convertible
Preferred Stock will be payable on a cumulative basis when, as and if declared by our board of directors, or an authorized committee thereof, at an annual rate of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% of the liquidation preference of
$200.00 per share of Mandatory Convertible Preferred Stock, and may be paid in cash (subject to limitations imposed by the terms of our indebtedness) or, subject to certain limitations, in shares of our common stock, or in any combination of cash
and shares of our common stock. If declared, dividends on the Mandatory Convertible Preferred Stock will be payable quarterly on January&nbsp;1, April&nbsp;1, July&nbsp;1 and October&nbsp;1 of each year, commencing on October&nbsp;1, 2020 and ending
on, and including, July&nbsp;1, 2023. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We estimate that the net proceeds to us from the Concurrent Mandatory Convertible Preferred Stock
Offering, after deducting issuance costs and discounts, will be approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(or approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if the underwriters in the Concurrent Mandatory Convertible Preferred Stock Offering exercise their option to purchase additional shares of Mandatory
Convertible Preferred Stock to cover over-allotments, if any, in full). There can be no assurance that the Concurrent Mandatory Convertible Preferred Stock Offering will be completed. Completion of this offering of shares of our common stock is not
contingent upon the Concurrent Mandatory Convertible Preferred Stock Offering, and the completion of the Concurrent Mandatory Convertible Preferred Stock Offering is not contingent upon the completion this offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our common stock will rank junior to our Mandatory Convertible Preferred Stock, if issued, with respect to the payment of dividends and
amounts payable in the event of our liquidation, dissolution or winding up of our affairs. Subject to certain exceptions, so long as any share of Mandatory Convertible Preferred Stock remains outstanding, no dividend or distributions will be
declared or paid on shares of our common stock or any other class or series of stock ranking junior to the Mandatory Convertible Preferred Stock, and no common stock or any other class or series stock ranking junior to or on parity with the
Mandatory Convertible Preferred Stock shall be, directly or indirectly, purchased, redeemed, or otherwise acquired for consideration by us or any of our subsidiaries unless all accumulated and unpaid dividends for all preceding dividend periods have
been declared and paid upon, or a sufficient sum of cash or number of shares of our common stock has been set aside for the payment of such dividends upon, all outstanding shares of Mandatory Convertible Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In addition, upon our voluntary or involuntary liquidation, <FONT STYLE="white-space:nowrap">winding-up</FONT> or dissolution, each holder of
Mandatory Convertible Preferred Stock will be entitled to receive a liquidation preference in the amount of $200.00 per share of Mandatory Convertible Preferred Stock, plus an amount equal to accumulated and unpaid dividends on such shares, whether
or not declared, to, but excluding, the date fixed for liquidation, <FONT STYLE="white-space:nowrap">winding-up</FONT> or dissolution, to be paid out of our assets legally available for distribution to our shareholders after satisfaction of
indebtedness and other liabilities to our creditors and holders of shares of our capital stock ranking senior to the Mandatory Convertible Preferred Stock as to distribution rights upon our liquidation,
<FONT STYLE="white-space:nowrap">winding-up</FONT> or dissolution, and before any payment or distribution is made to holders of any class or series of our capital stock ranking junior to the Mandatory Convertible Preferred Stock as to distribution
rights upon our liquidation, <FONT STYLE="white-space:nowrap">winding-up</FONT> or dissolution, including, without limitation, our common stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-17 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The holders of the Mandatory Convertible Preferred Stock will not have voting rights except as
described below and as specifically required by Pennsylvania law from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Whenever dividends on any shares of the Mandatory
Convertible Preferred Stock have not been declared and paid for the equivalent of six or more dividend periods, whether or not for consecutive dividend periods (a &#147;nonpayment&#148;), the authorized number of directors on our board of directors
will, at the next annual meeting of shareholders or at a special meeting of shareholders as provided below, automatically be increased by two and the holders of record of such shares of the Mandatory Convertible Preferred Stock, voting together as a
single class with holders of record of any and all other series of voting preferred stock (as defined below) then outstanding, will be entitled, at our next annual meeting of shareholders or at a special meeting of shareholders, to vote for the
election of a total of two additional members of our board of directors (the &#147;preferred stock directors&#148;); provided that the election of any such directors will not cause us to violate the corporate governance requirements of The Nasdaq
Global Select Market (or any other exchange or automated quotation system on which our securities may be listed or quoted) that requires listed or quoted companies to have a majority of independent directors; and provided further that our board of
directors shall, at no time, include more than two preferred stock directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In the event of a nonpayment, the holders of at least 25%
of the shares of the Mandatory Convertible Preferred Stock and any other series of voting preferred stock may request that a special meeting of shareholders be called to elect such preferred stock directors (provided, however, to the extent
permitted by our amended and restated bylaws, if our next annual meeting of shareholders or a special meeting of shareholders is scheduled to be held within 90 days of the receipt of such request, the election of such preferred stock directors will
be included in the agenda for and will be held at such scheduled annual or special meeting of shareholders). The preferred stock directors will stand for reelection annually, at each subsequent annual meeting of the shareholders, so long as the
holders of the Mandatory Convertible Preferred Stock continue to have such voting rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">At any meeting at which the holders of the
Mandatory Convertible Preferred Stock are entitled to elect preferred stock directors, the holders of a majority of the then outstanding shares of the Mandatory Convertible Preferred Stock and all other series of voting preferred stock, present in
person or represented by proxy, will constitute a quorum and the vote of the holders of a majority of such shares of the Mandatory Convertible Preferred Stock and other voting preferred stock so present or represented by proxy at any such meeting at
which there shall be a quorum shall be sufficient to elect the preferred stock directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As used in this prospectus supplement,
&#147;voting preferred stock&#148; means any class or series of our capital stock, in addition to and established after the initial issuance of the Mandatory Convertible Preferred Stock, ranking on parity with the Mandatory Convertible Preferred
Stock as to dividends and distribution rights upon our liquidation, winding up or dissolution and upon which like voting rights for the election of directors have been conferred and are exercisable. Whether a plurality, majority or other portion in
voting power of the Mandatory Convertible Preferred Stock and any other voting preferred stock have been voted in favor of any matter shall be determined by reference to the respective liquidation preference amounts of the Mandatory Convertible
Preferred Stock and such other voting preferred stock voted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">If and when all accumulated and unpaid dividends have been paid in full, or
declared and a sum or number of shares of our common stock sufficient for such payment shall have been set aside for the benefit of the holders thereof (a &#147;nonpayment remedy&#148;), the holders of the Mandatory Convertible Preferred Stock shall
immediately and, without any further action by us, be divested of the foregoing voting rights, subject to the revesting of such rights in the event of each subsequent nonpayment. If such voting rights for the holders of the Mandatory Convertible
Preferred Stock and all other holders of voting preferred stock have terminated, the term of office of each preferred stock director so elected will terminate at such time and the authorized number of directors on our board of directors shall
automatically decrease by two. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-18 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Any preferred stock director may be removed at any time, with cause as provided by law or without
cause by the holders of record of a majority in voting power of the outstanding shares of the Mandatory Convertible Preferred Stock and any other series of voting preferred stock then outstanding (voting together as a class) when they have the
voting rights described above. In the event that a nonpayment shall have occurred and there shall not have been a nonpayment remedy, any vacancy in the office of a preferred stock director (other than prior to the initial election after a
nonpayment) may be filled by the written consent of the preferred stock director remaining in office, except in the event that such vacancy is created as a result of such preferred stock director being removed or if no preferred stock director
remains in office, such vacancy may be filled by a vote of the holders of record of a majority in voting power of the outstanding shares of the Mandatory Convertible Preferred Stock and any other series of voting preferred stock then outstanding
(voting together as a single class) when they have the voting rights described above; provided that the election of any such preferred stock directors will not cause us to violate the corporate governance requirements of The Nasdaq Global Select
Market (or any other exchange or automated quotation system on which our securities may be listed or quoted) that requires listed or quoted companies to have a majority of independent directors. The preferred stock directors will each be entitled to
one vote per director on any matter that comes before our board of directors for a vote. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Mandatory Convertible Preferred Stock will
have certain other voting rights with respect to certain amendments to our amended and restated articles of incorporation or the statement with respect to shares establishing the terms of the Mandatory Convertible Preferred Stock or certain other
transactions as described in such statement with respect to shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The foregoing information concerning the Mandatory Convertible
Preferred Stock is not complete and is subject to, and qualified in its entirety by reference to, the provisions of the Statement with Respect to Shares establishing the terms of the Mandatory Convertible Preferred Stock, a copy of which has been or
will be incorporated by reference as an exhibit into the registration statement of which this prospectus supplement and the accompanying prospectus form a part and which may be obtained as described under &#147;Where You Can Find More
Information&#148;. In addition, a description of the proposed Mandatory Convertible Preferred Stock is set forth in the separate prospectus supplement pursuant to which such Mandatory Convertible Preferred Stock is being offered. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc32995_9"></A>DIVIDEND POLICY ON COMMON STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We have never paid cash dividends on our common stock and do not anticipate paying any cash dividends on our common stock in the foreseeable
future. The Credit Agreement and the terms of the Mandatory Convertible Preferred Stock restrict our ability to pay cash dividends on our common stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-19 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc32995_10"></A>CAPITALIZATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following table sets forth our cash and cash equivalents, short-term debt and total capitalization, in each case, as of March&nbsp;31,
2020: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on an actual basis; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on an as adjusted basis giving effect to (i)&nbsp;the issuance and sale
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock in this offering, after deducting the underwriters&#146; discounts and commissions and estimated offering expenses payable by us
(assuming no exercise of the underwriters&#146; option to purchase additional shares of common stock) and (ii)&nbsp;the use of approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million of
the net proceeds from this offering, the Concurrent Mandatory Convertible Preferred Stock Offering and/or cash on hand to repay borrowings (including accrued interest) under the Credit Agreement; and </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on a pro forma basis as adjusted to give further effect to the issuance and sale of an aggregate amount
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of Mandatory Convertible Preferred Stock after deducting underwriting discounts and commissions and estimated offering expenses payable by us in
the Concurrent Mandatory Convertible Preferred Stock Offering (assuming no exercise of the underwriters&#146; over-allotment option to purchase additional shares of Mandatory Convertible Preferred Stock in the Concurrent Mandatory Convertible
Preferred Stock Offering), assuming the Concurrent Mandatory Convertible Preferred Stock Offering is consummated. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The
information in the table below is illustrative only, and our capitalization following the completion of this offering and the Concurrent Mandatory Convertible Preferred Stock Offering, if it is completed, will depend on the final terms of each
offering. Moreover, because the completion of this offering is not contingent on the completion of the Concurrent Mandatory Convertible Preferred Stock Offering, you should not assume that the Concurrent Mandatory Convertible Preferred Stock
Offering, as reflected in the &#147;Pro Forma As Adjusted&#148; column in the table below, will take place. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">You should read this table
together with the &#147;Use of Proceeds&#148; section in this prospectus supplement, as well as the information contained in our consolidated financial statements and related notes incorporated by reference in this prospectus supplement. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>As of March&nbsp;31, 2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>(amounts in thousands, except share and per share data and
footnotes)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Actual</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>As<BR>Adjusted</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Pro&nbsp;Forma<BR>As&nbsp;Adjusted</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" COLSPAN="9" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 388,107</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total debt:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Term A Facility, interest at LIBOR, as defined, plus 2.00%</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,209,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revolving Credit Facility, interest at LIBOR, as defined, plus 2.00%</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debt issuance costs, Term A Facility and Revolving Credit Facility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(33,928</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Term B Facility, interest at LIBOR, as defined, plus 3.50%</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">716,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debt issuance costs, Term B Facility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(25,892</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">0.50% convertible senior notes due 2036, assumed in the Finisar acquisition</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,888</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">0.25% convertible senior notes due 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">345,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">0.25% convertible senior notes unamortized discount attributable to cash conversion option and
debt issuance costs including initial purchasers&#146; discount</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(34,019</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,282,424</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less current portion of long-term debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(69,250</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Long-term debt, net of current portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,213,174</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-20 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>As of March&nbsp;31, 2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>(amounts in thousands, except share and per share data and
footnotes)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Actual</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>As<BR>Adjusted</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Pro&nbsp;Forma<BR>As&nbsp;Adjusted</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shareholders&#146; equity:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock, no par value; authorized &#150; 300,000,000 shares; issued &#150; 104,278,333
shares, actual; issued &#150; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares, as adjusted and pro forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,459,354</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preferred stock, no par value; authorized &#150; 5,000,000 shares; none issued, actual and as
adjusted; of which &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares are designated as &nbsp;&nbsp;&nbsp;&nbsp;% Series A Mandatory Convertible Preferred Stock, pro forma as adjusted; none issued, actual and as
adjusted; issued &#150; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares, pro forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated other comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(80,444</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Retained earnings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">825,291</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Treasury stock, at cost &#150; 13,102,618 shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(186,294</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total shareholders&#146; equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,017,907</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total capitalization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,300,332</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The table above excludes: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">4,178,069 shares subject to outstanding stock options at a weighted average exercise price of $26.04 per share;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">3,477,231 shares subject to outstanding unvested restricted share unit awards as of March&nbsp;31, 2020;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">409,246 shares subject to outstanding performance share unit awards as of March&nbsp;31, 2020;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">3,176,426 additional shares of common stock reserved for issuance under our equity incentive plan; and
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any shares issuable upon conversion of the 2022 notes, the Finisar convertible notes and the Mandatory
Convertible Preferred Stock (if the Concurrent Mandatory Convertible Preferred Stock Offering is completed). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-21 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc32995_11"></A>DESCRIPTION OF COMMON STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following summary description of our common stock is based on the provisions of our Articles of Incorporation, By-Laws and the applicable
provisions of the BCL. This information may not be complete in all respects and is qualified entirely by reference to the provisions of our Articles of Incorporation, <FONT STYLE="white-space:nowrap">By-Laws</FONT> and the BCL. For information on
how to obtain copies of our Articles of Incorporation and <FONT STYLE="white-space:nowrap">By-Laws,</FONT> see the discussion above under the heading &#147;Where You Can Find More Information.&#148; As of the date of this prospectus supplement, our
authorized capital stock consists of 300,000,000 shares of common stock and 5,000,000 shares of preferred stock, no par value per share. No shares of preferred stock are currently outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As of June&nbsp;26, 2020,
we had 92,254,445 shares of common stock outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Voting Rights </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Each outstanding share of our common stock is entitled to one vote on all matters submitted to a vote of shareholders. There is no cumulative
voting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Dividend and Liquidation Rights </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The holders of outstanding shares of our common stock are entitled to receive dividends out of assets legally available for the payment of
dividends at the times and in the amounts as our board of directors may from time to time determine. Holders of our common stock have no preemptive or subscription rights to purchase any of our securities and no sinking fund provisions apply to our
common stock. Upon the liquidation, dissolution or winding up of the Company, the holders of our common stock are entitled to receive pro rata the assets of the Company which are legally available for distribution, after payment of all debts and
other liabilities and subject to the prior rights of any holders of preferred stock then outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We have never paid any cash
dividends on our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Fully Paid and <FONT STYLE="white-space:nowrap">Non-Assessable</FONT> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">All outstanding shares of our common stock are fully paid and <FONT STYLE="white-space:nowrap">non-assessable.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Nasdaq Listing </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our common stock
is listed on The Nasdaq Global Select Market under the symbol &#147;IIVI.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Transfer Agent and Registrar </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The transfer agent and registrar for our common stock is American Stock Transfer and Trust Company,&nbsp;LLC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Anti-Takeover Law Provisions </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Certain provisions of Pennsylvania law and our Articles of Incorporation and our By-Laws could make the acquisition of the Company by means of
a tender offer, or the acquisition of control of the Company by means of a proxy contest or otherwise more difficult. These provisions, summarized below, are intended to discourage certain types of coercive takeover practices and inadequate takeover
bids, and are designed to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-22 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
encourage persons seeking to acquire control of the Company to negotiate with our board of directors. We believe that the benefits of increased protection against an unfriendly or unsolicited
proposal to acquire or restructure the Company outweigh the disadvantages of discouraging such proposals. Among other things, negotiation of such proposals could result in an improvement of their terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Pennsylvania State Law Provisions </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We are subject to various anti-takeover provisions of the Pennsylvania Business Corporation Law (the &#147;BCL&#148;). Many of these
provisions are triggered if any person or group acquires, or discloses intent to acquire, 20% or more of a Pennsylvania corporation&#146;s voting power, subject to certain exceptions. These provisions: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provide the other shareholders of the corporation with certain rights against the acquiring group or person;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prohibit the corporation from engaging in a broad range of business combinations with the acquiring group or
person; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prohibit the corporation from engaging in a broad range of business combinations with the acquiring group or
person; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">restrict the voting and other rights of the acquiring group or person; and </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provide that certain profits realized by the acquiring group or person from the sale of a corporation&#146;s
equity securities belong to and are recoverable by such corporation. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Regardless of the amount of a person&#146;s
holdings, if a shareholder or shareholder group (including affiliated persons) would be a party to certain proposed transactions with the Company or would be treated differently from our other shareholders in certain proposed transactions, the BCL
requires approval by a majority of votes entitled to be cast by all shareholders other than the interested shareholder or affiliate group, unless the transaction is approved by independent directors or other criteria are satisfied. Furthermore,
under the BCL, a &#147;short-form&#148; merger of the Company cannot be implemented without the consent of our board of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In
addition, as permitted by Pennsylvania law, an amendment to our Articles of Incorporation or other corporate action that is approved by shareholders may provide mandatory special treatment for specified groups of
<FONT STYLE="white-space:nowrap">non-consenting</FONT> shareholders of the same class. For example, an amendment to our Articles of Incorporation or other corporate action may provide that shares of our Common Stock held by designated shareholders
of record must be cashed out at a price determined by us, subject to applicable dissenters&#146; rights. In these cases, Pennsylvania law requires either a special class vote or dissenters&#146; rights for holders of the group designated for special
treatment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Furthermore, the BCL provides that directors may, in discharging their duties, consider, to the extent they deem appropriate,
the effects of any action upon shareholders, employees, suppliers, customers and the communities in which its offices are located. Directors are not required to consider the interests of shareholders to a greater degree than other
constituencies&#146; interests. The BCL expressly provides that directors do not violate their fiduciary duties solely by relying on &#147;poison pills&#148; or the anti-takeover provisions of the BCL. We do not currently have a &#147;poison
pill.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Other Provisions in our Articles of Incorporation and our <FONT STYLE="white-space:nowrap">By-Laws</FONT> </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our Articles of Incorporation and our <FONT STYLE="white-space:nowrap">By-Laws</FONT> contain provisions that could make us a less attractive
target for a hostile takeover and could make more difficult or discourage a merger proposal, a tender offer or a proxy contest. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-23 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Such provisions include: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a requirement that shareholder-nominated director nominees be nominated in advance of the meeting at which
directors are elected and that specific information be provided in connection with such nomination; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability of our board of directors to issue additional shares of Common Stock or preferred stock without
shareholder approval; and </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain provisions requiring supermajority approval (at least <FONT STYLE="white-space:nowrap">two-thirds</FONT>
of the votes cast by all shareholders entitled to vote thereon, voting together as a single class). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Indemnification Of Directors
And Executive Officers And Limitation On Liability. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Pennsylvania Business Corporation Law </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Sections 1741 and 1742 of the BCL provide that a business corporation shall have the power to indemnify any person who was or is a party, or
is threatened to be made a party, to any proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that such person is or was a director, officer, employee or agent of the corporation, or is or was serving at the
request of the corporation as a director, officer, employee or agent of another corporation or other enterprise, against expenses (including attorneys&#146; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by
such person in connection with such proceeding, if such person acted in good faith and in a manner he reasonably believed to be in, or not opposed to, the best interests of the corporation, and, with respect to any criminal proceeding, had no
reasonable cause to believe his conduct was unlawful. In the case of an action by or in the right of the corporation, such indemnification is limited to expenses (including attorneys&#146; fees) actually and reasonably incurred by such person in
connection with the defense or settlement of such action, except that no indemnification shall be made in respect of any claim, issue or matter as to which such person has been adjudged to be liable to the corporation unless, and only to the extent
that, a court determines upon application that, despite the adjudication of liability but in view of all the circumstances, such person is fairly and reasonably entitled to indemnity for the expenses that the court deems proper. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">BCL Section&nbsp;1744 provides that, unless ordered by a court, any indemnification referred to above shall be made by the corporation only as
authorized in the specific case upon a determination that indemnification is proper in the circumstances because the indemnitee has met the applicable standard of conduct. Such determination shall be made: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by the Board of Directors by a majority vote of a quorum consisting of directors who were not parties to the
proceeding; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if such a quorum is not obtainable, or if obtainable and a majority vote of a quorum of disinterested directors
so directs, by independent legal counsel in a written opinion; or </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by the shareholders. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Notwithstanding the above, BCL Section&nbsp;1743 provides that to the extent that a director, officer, employee or agent of a business
corporation is successful on the merits or otherwise in defense of any proceeding referred to in BCL Section&nbsp;1741 or 1742, or in defense of any claim, issue or matter therein, such person shall be indemnified against expenses (including
attorneys&#146; fees) actually and reasonably incurred by such person in connection therewith. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-24 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">BCL Section&nbsp;1745 provides that expenses (including attorneys&#146; fees) incurred by an
officer, director, employee or agent of a business corporation in defending any proceeding may be paid by the corporation in advance of the final disposition of the proceeding upon receipt of an undertaking by the indemnitee to repay the amount
advanced if it is ultimately determined that the indemnitee is not entitled to be indemnified by the corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">BCL Section&nbsp;1746
provides that the indemnification and advancement of expenses provided by, or granted pursuant to, the foregoing provisions is not exclusive of any other rights to which a person seeking indemnification or advancement of expenses may be entitled
under any bylaw, agreement, vote of shareholders or disinterested directors or otherwise, and that indemnification may be granted under any bylaw, agreement, vote of shareholders or disinterested directors or otherwise for any action taken or any
failure to take any action whether or not the corporation would have the power to indemnify the person under any other provision of law and whether or not the indemnified liability arises or arose from any action by or in the right of the
corporation, provided, however, that no indemnification may be made in any case where the act or failure to act giving rise to the claim for indemnification is determined by a court to have constituted willful misconduct or recklessness. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">BCL Section&nbsp;1747 permits a Pennsylvania business corporation to purchase and maintain insurance on behalf of any person who is or was a
director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation or other enterprise, against any liability asserted against such person
and incurred by such person in any such capacity, or arising out of such person&#146;s status as such, whether or not the corporation would have the power to indemnify the person against such liability under the provisions described above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">BCL Sections 1748 and 1749 extend the indemnification and advancement of expenses provisions to successor corporations in consolidations,
mergers or divisions and to representatives serving as fiduciaries of employee benefit plans. BCL Section&nbsp;1750 provides that the indemnification and advancement of expenses provided by, or granted pursuant to, Subchapter E of the BCL, shall,
unless otherwise provided when authorized or ratified, continue as to a person who has ceased to be a representative of the corporation and shall inure to the benefit of the heirs and personal representative of such person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">By-Laws</FONT> </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Article VI of our <FONT STYLE="white-space:nowrap">By-Laws</FONT> provides that the directors and officers of the registrant shall be
indemnified to the fullest extent not prohibited by law in connection with any actual or threatened action, suit or proceeding, civil, criminal, administrative, investigative or other (whether brought by or in the right of the registrant or
otherwise) arising out of their service to the registrant or to another corporation, partnership, joint venture, trust or other enterprise at the request of the registrant, with certain limitations and exceptions. Article VI of our <FONT
STYLE="white-space:nowrap">By-Laws</FONT> also provides that our employees and agents who are not directors or officers may be indemnified with such scope and effect as determined by the registrant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Article VI of our <FONT STYLE="white-space:nowrap">By-Laws</FONT> also provides that we may purchase and maintain insurance to protect itself
and any director, officer, agent or employee against any liability asserted against and incurred by him or her in respect of such service, whether or not the registrant would have the power to indemnify him or her against such liability by law or
under the provisions of the <FONT STYLE="white-space:nowrap">By-Laws.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As permitted by BCL Section&nbsp;1713, our <FONT
STYLE="white-space:nowrap">By-Laws</FONT> provide that directors shall not be personally liable to the registrant for monetary damages for any action taken, or any failure to take any action, unless, (A)&nbsp;the director has breached or failed to
perform the duties of his/her office under certain provisions of the <FONT STYLE="white-space:nowrap">By-Laws</FONT> relating to standard of care and justifiable reliance; and (B)&nbsp;the breach or failure to perform constitutes self-dealing,
willful misconduct or recklessness. The BCL states that this exculpation from liability does not apply to the responsibility or liability of a director pursuant to any criminal statute or the liability of a director for the payment of taxes pursuant
to federal, state or local law. It may also not apply to liabilities imposed upon directors </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-25 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
by the Federal securities laws. BCL Section&nbsp;1715(d) creates a presumption, subject to exceptions, that a director acted in the best interests of the corporation. BCL Section&nbsp;1712, in
defining the standard of care a director owes to the corporation, provides that a director stands in a fiduciary relation to the corporation and must perform his duties as a director or as a member of any committee of the Board of Directors in good
faith, in a manner he reasonably believes to be in the best interests of the corporation and with such care, including reasonable inquiry, skill and diligence, as a person of ordinary prudence would use under similar circumstances. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Director and Officer Liability Insurance </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We maintain directors&#146; and officers&#146; liability insurance covering our directors and officers with respect to liability which they
may incur in connection with their serving as such, which liability could include liability under the Securities Act of 1933. Under the insurance, we are entitled to reimbursement for amounts as to which the directors and officers are indemnified
under the indemnification provisions of our <FONT STYLE="white-space:nowrap">By-Laws.</FONT> The insurance may also provide certain additional coverage for the directors and officers against certain liability even though such liability is not
subject to the indemnification provisions of our <FONT STYLE="white-space:nowrap">By-Laws.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-26 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc32995_12"></A>MATERIAL U.S. FEDERAL INCOME AND ESTATE TAX CONSIDERATIONS
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR <FONT STYLE="white-space:nowrap">NON-U.S.</FONT> HOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following discussion summarizes the material U.S. federal income and estate tax considerations relating to the acquisition, ownership and
disposition of our common stock purchased in this offering by a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder (as defined below). This discussion is based on the provisions of the Internal Revenue Code of 1986, as amended (or the
&#147;Code&#148;), final, temporary and proposed U.S. Treasury regulations promulgated thereunder and current administrative rulings and judicial decisions, all as in effect as of the date hereof. All of these authorities may be subject to differing
interpretations or repealed, revoked or modified, possibly with retroactive effect, which could materially alter the tax consequences to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders described in this prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">There can be no assurance that the Internal Revenue Service (the &#147;IRS&#148;) will not take a contrary position to the tax consequences
described herein or that such position will not be sustained by a court. No ruling from the IRS has been requested or obtained with respect to the U.S. federal income or estate tax consequences to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT>
holder of the purchase, ownership or disposition of our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">This discussion is for general information only and is not tax
advice. All prospective <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders of our common stock should consult their own tax advisors with respect to the U.S. federal, state, local and <FONT STYLE="white-space:nowrap">non-U.S.</FONT> tax
consequences of the purchase, ownership and disposition of our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As used in this discussion, a
<FONT STYLE="white-space:nowrap">&#147;non-U.S.</FONT> holder&#148; is, for U.S. federal income tax purposes, a beneficial owner of our common stock that is not a U.S. holder. A &#147;U.S. holder&#148; means a beneficial owner of our common stock
that is, for U.S. federal income tax purposes, (a)&nbsp;an individual who is a citizen or resident of the United States, (b)&nbsp;a corporation or other entity treated as a corporation for U.S. federal income tax purposes created or organized in or
under the laws of the United States, any state thereof or the District of Columbia, (c)&nbsp;an estate the income of which is subject to U.S. federal income taxation regardless of its source, or (d)&nbsp;a trust if it (1)&nbsp;is subject to the
primary supervision of a court within the United States and one or more &#147;U.S. persons&#148; (within the meaning of the Code) have the authority to control all substantial decisions of the trust or (2)&nbsp;has a valid election in effect under
applicable U.S. Treasury regulations to be treated as a U.S. person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">An individual may be treated, for U.S. federal income tax purposes,
as a resident of the United States in any calendar year by being present in the United States on at least 31&nbsp;days in that calendar year and for an aggregate of at least 183&nbsp;days during a three-year period ending in that calendar year. The <FONT
STYLE="white-space:nowrap">183-day</FONT> test is determined by counting all of the days the individual is treated as being present in the current year, <FONT STYLE="white-space:nowrap">one-third</FONT> of such days in the immediately preceding year
and <FONT STYLE="white-space:nowrap">one-sixth</FONT> of such days in the second preceding year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">This discussion assumes that a
prospective <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder will hold shares of our common stock as a capital asset within the meaning of the Code (generally, property held for investment). This discussion does not address all aspects of
U.S. federal income and estate taxation that may be relevant to a particular <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder in light of that <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s individual circumstances. In
addition, this discussion does not address any aspect of the U.S. federal alternative minimum tax, the Medicare contribution tax, U.S. state or local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> taxes, or the special tax rules applicable to
particular <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders, such as: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">insurance companies and financial institutions; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">tax-exempt</FONT> organizations; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">pension plans; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">controlled foreign corporations; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">passive foreign investment companies; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-27 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">brokers and dealers in securities; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons that hold our common stock as part of a straddle, conversion transaction, or other integrated investment;
and </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">former citizens or residents of the United States subject to tax as expatriates. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">If a partnership or other entity treated as a partnership for U.S. federal income tax purposes is an owner of our common stock, the treatment
of a partner in the partnership generally will depend on the status of the partner and the activities of the partnership. We urge any owner of our common stock that is a partnership and partners in that partnership to consult their tax advisors
regarding the U.S. federal income and estate tax consequences of purchasing, owning and disposing of our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Distributions on Our Common
Stock </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Any distribution on our common stock paid to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders will generally constitute
a dividend for U.S. federal income tax purposes to the extent paid from our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. Distributions in excess of our current and accumulated earnings and
profits will generally constitute a return of capital to the extent of the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s adjusted tax basis in our common stock, and will be applied against and reduce the <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s adjusted tax basis. Any remaining excess will be treated as capital gain, subject to the tax treatment described below in &#147;&#151;Gain on Sale, Exchange or Other Disposition of Our Common
Stock.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Subject to the discussions below regarding backup withholding and the FATCA, dividends paid to a <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder that are not treated as effectively connected with the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s conduct of a trade or business in the United States generally will be subject to
withholding of U.S. federal income tax at a rate of 30% on the gross amount paid, unless the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is entitled to an exemption from or reduced rate of withholding under an applicable income tax
treaty. In order to claim the benefit of an income tax treaty, a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder must provide a properly executed IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN</FONT> or
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E,</FONT></FONT> as applicable (or successor form to either), certifying under penalties of perjury that such <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is
entitled to benefits under the applicable income tax treaty and has complied with any special certification requirements prior to the payment of dividends. A <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder eligible for a reduced rate of
withholding pursuant to an income tax treaty may be eligible to obtain a refund of any excess amounts withheld by timely filing an appropriate claim for a refund with the IRS. <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders should consult
their tax advisors regarding possible entitlements to benefits under any income tax treaty. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Dividends paid to a <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder that are treated as effectively connected with a trade or business conducted by the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder within the United States (and, if an applicable income tax
treaty so provides, are also attributable to a permanent establishment or a fixed base maintained within the United States by the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder) are generally exempt from the 30% withholding tax. To
establish the exemption, a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder must provide a properly executed IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8ECI</FONT> (or successor form) prior to the payment of the dividend. Dividends
received by a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder that are treated as effectively connected with a U.S. trade or business generally are subject to U.S. federal income tax at rates applicable to U.S. persons. A <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder that is a corporation may, under certain circumstances, be subject to an additional &#147;branch profits tax&#148; imposed at a rate of 30%, or such lower rate as specified by an applicable income
tax treaty between the United States and such <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s country of residence, on its effectively connected earnings and profits, with certain adjustments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Gain On Sale, Exchange or Other Disposition of Our Common Stock </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Subject to the discussion below regarding backup withholding, a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder will generally not be
subject to any U.S. federal income tax or withholding on any gain realized from the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s sale, exchange or other disposition of shares of our common stock unless: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-28 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the gain is effectively connected with a U.S. trade or business (and, if an applicable income tax treaty so
provides, is also attributable to a permanent establishment or a fixed base maintained within the United States by the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder), in which case the gain will be taxed on a
<FONT STYLE="white-space:nowrap">net-income</FONT> basis, generally in the same manner as if the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder were a U.S. person, and, if the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is a
corporation, the additional branch profits tax described above in &#147;&#151;Distributions on Our Common Stock&#148; may also apply; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is an individual who is present in the United States
for 183&nbsp;days or more in the taxable year of the disposition and certain other conditions are met, in which case the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder will be subject to a 30% tax on the net gain derived from the
disposition, which may be offset by U.S.-source capital losses of the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder, if any; or </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we are, or have been at any time during the five-year period preceding such disposition (or the <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s holding period, if shorter), a &#147;United States real property holding corporation&#148; (or &#147;USRPHC&#148;) under Section&nbsp;897 of the Code. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Generally, we will be a USRPHC if the fair market value of our U.S. real property interests equals or exceeds 50% of the sum of the fair
market values of our worldwide real property interests and other assets used or held for use in a trade or business, all as determined under applicable U.S. Treasury regulations. We believe that we have not been and are not currently, and do not
anticipate becoming in the future, a USRPHC for U.S. federal income tax purposes. However, because the determination of whether we are a USRPHC depends on the fair market value of our United States real property relative to the fair market value of
our other business assets, there can be no assurance that we will not become a USRPHC in the future. Even if we become a USRPHC, however, as long as our common stock is regularly traded on an established securities market, such common stock will be
treated as a United States real property interest only for a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder who actually or constructively holds more than five percent of such regularly traded common stock at any time during the shorter of
the five-year period ending on the date of the sale or other taxable disposition and the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s holding period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Information Reporting and Backup Withholding </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The applicable withholding agent must report annually to the IRS and to each <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder the
amount of distributions paid to such <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder and the amount of tax withheld, if any. Copies of the information returns filed with the IRS to report the distributions and withholding may also be made
available to the tax authorities in a country in which the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is a resident under the provisions of an applicable income tax treaty or agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The United States imposes backup withholding, currently at a rate of 24%, on the gross amount of dividends and certain other types of
payments. Dividends paid to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder will not be subject to backup withholding if proper certification of foreign status (usually on IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN</FONT> or <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E,</FONT></FONT> as applicable) is provided, and the payor does not have actual knowledge or reason to know that the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is a U.S.
person. In addition, no backup withholding or information reporting will be required regarding the proceeds of a disposition of our common stock made by a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder within the United States or conducted
through certain U.S. financial intermediaries if the payor receives the certification of foreign status described in the preceding sentence and does not have actual knowledge or reason to know that such
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is a U.S. person or the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder otherwise establishes an exemption. <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders should consult their
tax advisors regarding the application of the information reporting and backup withholding rules to them. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Backup withholding is not an
additional tax. Rather, amounts withheld under the backup withholding rules from a payment to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder can be refunded or credited against the <FONT STYLE="white-space:nowrap">non-U.S.</FONT>
holder&#146;s U.S. federal income tax liability, if any, provided that certain required information is furnished to the IRS in a timely manner. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-29 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>U.S. Federal Estate Tax </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">An individual <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder who is treated as the owner, or who has made certain lifetime transfers,
of an interest in our common stock will be required to include the value of the common stock in his or her gross estate for U.S. federal estate tax purposes and may be subject to U.S. federal estate tax, unless an applicable estate or other tax
treaty provides otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FATCA </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In addition to the withholding described above, the Foreign Account Tax Compliance Act (or &#147;FATCA&#148;), imposes a 30% withholding tax
on dividend payments made by a U.S. person to a foreign financial institution or <FONT STYLE="white-space:nowrap">non-financial</FONT> foreign entity (including, in some cases, when a foreign financial institution or nonfinancial foreign entity is
acting as an intermediary), unless (i)&nbsp;in the case of a foreign financial institution, such institution enters into (or is deemed to have entered into) an agreement with the U.S. Treasury Department to withhold on certain payments, and to
collect and provide to the U.S. Treasury Department substantial information regarding U.S. account holders of such institution (which includes certain equity and debt holders of such institution, as well as certain account holders that are foreign
entities with U.S. owners), (ii)&nbsp;in the case of a <FONT STYLE="white-space:nowrap">non-financial</FONT> foreign entity, such entity provides the withholding agent with a certification identifying the direct and indirect substantial U.S. owners
of the entity, or (iii)&nbsp;the foreign financial institution or <FONT STYLE="white-space:nowrap">non-financial</FONT> foreign entity otherwise qualifies for an exemption from these rules. Under proposed Treasury regulations, this withholding tax
will not apply to the gross proceeds from the sale or other disposition of shares of our common stock. The preamble to these proposed Treasury regulations states that taxpayers may rely on them pending their finalization. An intergovernmental
agreement between the United States and an applicable foreign country may modify these requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders should consult their tax advisors regarding the possible implications of FATCA to
them in connection with the purchase, ownership and disposition of our common stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-30 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc32995_13"></A>UNDERWRITING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Subject to the terms and conditions set forth in the underwriting agreement, dated July&nbsp;&nbsp;&nbsp;&nbsp;, 2020, among us and BofA
Securities, Inc., J.P. Morgan Securities LLC and Citigroup Global Markets Inc. as representatives of the several underwriters, we will agree to sell to the underwriters, and each of the underwriters will agree, severally and not jointly, to purchase
from us, the number of shares of common stock set forth opposite its name below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85.5%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Underwriter</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Number&nbsp;of<BR>Shares</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BofA Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The underwriting agreement will provide that the obligations of the underwriters are subject to certain
conditions precedent such as the receipt by the underwriters of officers&#146; certificates and legal opinions and approval of certain legal matters by its counsel. Subject to the terms and conditions set forth in the underwriting agreement, the
underwriters will agree, severally and not jointly, to purchase all of the shares of common stock sold under the underwriting agreement if any of the shares are purchased. If an underwriter defaults, the underwriting agreement will provide that the
purchase commitments of the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> underwriters may be increased or the underwriting agreement may be terminated. We will agree to indemnify the underwriters and certain of their controlling persons
against certain liabilities, including liabilities under the Securities Act, and to contribute to payments that the underwriters may be required to make in respect of those liabilities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The underwriters have advised us that, following the completion of this offering, they currently intend to make a market in the common stock
as permitted by applicable laws and regulations. However, the underwriters are not obligated to do so, and the underwriters may discontinue any market-making activities at any time without notice in their sole discretion. Accordingly, no assurance
can be given as to the liquidity of the trading market for the common stock, that you will be able to sell any of the common stock held by you at a particular time or that the prices that you receive when you sell will be favorable. Sales of any
shares made outside of the United States may be made by affiliates of the underwriters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The underwriters are offering the shares of
common stock subject to their acceptance of the shares of common stock from us and subject to prior sale. The underwriters reserve the right to withdraw, cancel or modify offers to the public and to reject orders in whole or in part. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Commissions and Discounts </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The
representatives have advised us that the underwriters propose initially to offer the shares to the public at the public offering price set forth on the cover page of this prospectus supplement and to dealers at that price less a concession not in
excess of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share. After the initial offering of the shares, the public offering price, concession or any other term of the offering may be changed by the underwriters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following table shows the public offering price, underwriting discounts and commissions and proceeds before expenses to us. The
information assumes either no exercise or full exercise by the underwriters of their option to purchase additional shares of our common stock. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85.5%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="60%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Per&nbsp;Share</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>No&nbsp;Exercise</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Full&nbsp;Exercise</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Public offering price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underwriting discounts and commissions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds, before expenses, to us</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-31 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We estimate expenses payable by us in connection with this offering, other than the underwriting
discounts and commissions referred to above, will be approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Option to Purchase Additional Shares </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We
will grant an option to the underwriters, exercisable for 30 days after the date of this prospectus supplement, to purchase up to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; additional shares at the public offering price, less the underwriting
discounts and commissions. If the underwriters exercise this option, each underwriter will be obligated, subject to conditions contained in the underwriting agreement, to purchase the additional shares proportionate to that underwriter&#146;s
initial amount reflected in the above table. If the underwriters exercise this option, each underwriter will be obligated, subject to conditions contained in the underwriting agreement, to purchase the additional shares proportionate to that
underwriter&#146;s initial amount reflected in the above table. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No Sales of Similar Securities </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We will agree, and our executive officers and directors have agreed, not to sell or transfer any common stock or securities convertible into
or exchangeable or exercisable for common stock, for 60 days after the date of this prospectus, without first obtaining the written consent of the underwriters. Specifically, we will agree, and our executive officers and directors have agreed, with
certain limited exceptions, not to directly or indirectly: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">offer, pledge, sell or contract to sell any common stock; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">sell any option or contract to purchase any common stock; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">purchase any option or contract to sell any common stock: </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">grant any option, right or warrant for the sale of any common stock; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">otherwise dispose of or transfer any common stock, or any securities convertible into or exercisable or
exchangeable for common stock, or file any registration statement under the Securities Act with respect to any of the foregoing; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">request or demand that we file a registration statement related to the common stock; or </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">enter into any swap or other agreement or any transaction that transfers, in whole or in part, directly or
indirectly, the economic consequence of ownership of any common stock, whether any such swap, agreement or transaction is to be settled by delivery of shares or other securities, in cash or otherwise. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">These <FONT STYLE="white-space:nowrap">lock-up</FONT> provisions apply to common stock and to securities convertible into or exchangeable or
exercisable for common stock. They also apply to common stock owned now or acquired later by the person executing the agreement or over which the person executing the agreement later acquires the power of disposition. These <FONT
STYLE="white-space:nowrap">lock-up</FONT> provisions do not prevent any person from establishing a trading plan that complies with Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> under the Exchange Act or from amending such plan so long as there
are no sales of common stock under any such trading plan during the <FONT STYLE="white-space:nowrap">lock-up</FONT> period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The
restrictions described above do not apply to our executive officers with respect to transfers of shares of common stock: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">pursuant to a <FONT STYLE="white-space:nowrap">10b5-1</FONT> trading plan existing as of the date the party
becomes subject to the <FONT STYLE="white-space:nowrap">lock-up</FONT> restrictions; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">as a bona fide gift or gifts; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-32 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to any trust for the direct or indirect benefit of the party subject to the
<FONT STYLE="white-space:nowrap">lock-up</FONT> restrictions or the immediate family of the party subject to the <FONT STYLE="white-space:nowrap">lock-up</FONT> restrictions; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">as a distribution or other transfer by a partnership to its partners or former partners; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to the affiliates of the party subject to the <FONT STYLE="white-space:nowrap">lock-up</FONT> restrictions or to
any investment fund or other entity controlled or managed by the party subject to the <FONT STYLE="white-space:nowrap">lock-up;</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">pursuant to a qualified domestic relations order or in connection with a divorce settlement;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to any beneficiary of the party subject to the <FONT STYLE="white-space:nowrap">lock-up</FONT> restrictions
pursuant to a will or other testamentary document or applicable laws of decent upon the death of the party subject to the <FONT STYLE="white-space:nowrap">lock-up</FONT> restrictions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to us as a surrender of equity incentive awards granted under any equity incentive plans outstanding on the date
of this prospectus, whether in satisfaction of any tax withholding obligation in connection with the vesting of such award, or where such surrender is otherwise required pursuant to the term of such award; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">upon the completion of a bona fide third-party tender offer, merger, consolidation or other similar transaction
approved by our board of directors. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">lock-up</FONT> provisions summarized above will not apply to
us with respect to: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the sale and issuance of common stock in this offering; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the sale and issuance of shares of Mandatory Convertible Preferred Stock in the Concurrent Mandatory Convertible
Preferred Stock Offering, and the issuance of shares of common stock underlying such shares of Mandatory Convertible Preferred Stock; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any shares of common stock issued by us upon the exercise of an option or warrant, or the conversion of a
convertible security outstanding on the date of this prospectus; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any shares of our common stock issued or options to purchase common stock, restricted share awards or performance
share awards granted pursuant to any existing employee benefit plans or <FONT STYLE="white-space:nowrap">non-employee</FONT> director stock plans or dividend reinvestment plans; or </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the filing by us of any registration statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> or a successor
form thereto. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Nasdaq Global Select Market Listing </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our common stock is listed on The Nasdaq Global Select Market under the symbol &#147;IIVI.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Price Stabilization, Short Positions and Penalty Bids </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The underwriters have advised us that, pursuant to Regulation M under the Exchange Act, certain persons participating in the offering may
engage in short sale transactions, stabilizing transactions, syndicate covering transactions or the imposition of penalty bids in connection with this offering. These activities may have the effect of stabilizing or maintaining the market price of
the common stock at a level above that which might otherwise prevail in the open market. Establishing short sales positions may involve &#147;naked&#148; short sales. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">&#147;Naked&#148; short sales are sales made without the option to purchase additional shares of our common stock. The underwriters must close
out any naked short position by purchasing shares in the open market. A naked short position is more likely to be created if the underwriters are concerned that there may be downward pressure on the price of shares in the open market after pricing
that could adversely affect investors who purchase in this offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-33 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">A stabilizing bid is a bid for the purchase of shares of common stock on behalf of an underwriter
for the purpose of fixing or maintaining the price of the common stock. A syndicate covering transaction is the bid for or the purchase of shares of common stock on behalf of an underwriter to reduce a short position incurred by an underwriter in
connection with the offering. Similar to other purchase transactions, an underwriter&#146;s purchases to cover the syndicate short sales may have the effect of raising or maintaining the market price of our common stock or preventing or retarding a
decline in the market price of our common stock. As a result, the price of our common stock may be higher than the price that might otherwise exist in the open market. A penalty bid is an arrangement permitting an underwriter to reclaim the selling
concession otherwise accruing to a syndicate member in connection with the offering if the common stock originally sold by such syndicate member is purchased in a syndicate covering transaction and therefore have not been effectively placed by such
syndicate member. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Neither we, nor the underwriters make any representation or prediction as to the direction or magnitude of any effect
that the transactions described above may have on the price of our common stock. The underwriters are not obligated to engage in these activities and, if commenced, any of the activities may be discontinued at any time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Concurrent Mandatory Convertible Preferred Stock Offering </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We are offering 2,000,000 shares of our Mandatory Convertible Preferred Stock (or 2,300,000 shares if the underwriters of such offering
exercise in full their over-allotment option to purchase additional shares of Mandatory Convertible Preferred Stock) in an underwritten offering pursuant to a separate prospectus supplement (the &#147;Concurrent Mandatory Convertible Preferred Stock
Offering&#148;). This offering and the Concurrent Mandatory Convertible Preferred Stock Offering are not contingent upon one another. Certain of the underwriters in this offering are also the underwriters in the Concurrent Mandatory Convertible
Preferred Stock Offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Electronic Distribution </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In connection with the offering, the underwriters or securities dealers may distribute prospectuses by electronic means, such as <FONT
STYLE="white-space:nowrap">e-mail.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other Relationships </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The underwriters and certain of their affiliates are full service financial institutions engaged in various activities, which may include
securities trading, commercial and investment banking, financial advisory, investment management, investment research, principal investment, hedging, financing and brokerage activities. Certain of the underwriters are serving as underwriters in the
Concurrent Mandatory Convertible Preferred Stock Offering. The underwriters and certain of their affiliates may in the future engage in investment banking and other commercial dealings in the ordinary course of business with us and our affiliates,
for which they may in the future receive customary fees, commissions and expenses. For example, affiliates of BofA Securities, Inc. and J.P. Morgan Securities LLC are lenders under the Credit Agreement, and may receive net proceeds of this offering
upon repayment of amounts outstanding under the Credit Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In addition, in the ordinary course of their business activities, the
underwriters and their affiliates may make or hold a broad array of investments and actively trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their own account and for the
accounts of their customers. Such investments and securities activities may involve securities and/or instruments of ours or our affiliates. The underwriters and their affiliates may also make investment recommendations and/or publish or express
independent research views in respect of such securities or financial instruments and may hold, or recommend to clients that they acquire, long and/or short positions in such securities and instruments. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-34 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Selling Restrictions </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>European Economic Area and the United Kingdom </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In relation to each Member State of the European Economic Area and the United Kingdom (each a &#147;Relevant State&#148;), no shares of common
stock have been offered or will be offered pursuant to the offering to the public in that Relevant State prior to the publication of a prospectus in relation to the shares of common stock which has been approved by the competent authority in that
Relevant State or, where appropriate, approved in another Relevant State and notified to the competent authority in that Relevant State, all in accordance with the Prospectus Regulation), except that offers of the shares of common stock may be made
to the public in that Relevant State at any time under the following exemptions under the Prospectus Regulation: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to any legal entity which is a qualified investor as defined under the Prospectus Regulation;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to fewer than 150 natural or legal persons (other than qualified investors as defined under the Prospectus
Regulation), subject to obtaining the prior consent of the representatives for any such offer; or </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in any other circumstances falling within Article 1(4) of the Prospectus Regulation, </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">provided that no such offer of shares of common stock shall require the Issuer or any of the representatives to publish a prospectus pursuant to Article 3 of
the Prospectus Regulation or supplement a prospectus pursuant to Article 23 of the Prospectus Regulation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In the case of any shares of
common stock being offered to a financial intermediary as that term is used in Article 5(1) of the Prospectus Regulation, each such financial intermediary will be deemed to have represented, acknowledged and agreed that the shares of common stock
acquired by it in the offer have not been acquired on a <FONT STYLE="white-space:nowrap">non-discretionary</FONT> basis on behalf of, nor have they been acquired with a view to their offer or resale to, persons in circumstances which may give rise
to an offer to the public other than their offer or resale in a Relevant State to qualified investors, in circumstances in which the prior consent of the representative has been obtained to each such proposed offer or resale. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Company, the representatives and their affiliates will rely upon the truth and accuracy of the foregoing representations, acknowledgements
and agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">For the purposes of this provision, the expression an &#147;offer to the public&#148; in relation to any Shares in any
Relevant State means the communication in any form and by any means of sufficient information on the terms of the offer and any Shares to be offered so as to enable an investor to decide to purchase or subscribe for any Shares, and the expression
&#147;Prospectus Regulation&#148; means Regulation (EU) 2017/1129. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">References to the Prospectus Regulation includes, in relation to the
UK, the Prospectus Regulation as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The above
selling restriction is in addition to any other selling restrictions set out below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In connection with the offering, the representatives
are not acting for anyone other than the issuer and will not be responsible to anyone other than the issuer for providing the protections afforded to their clients nor for providing advice in relation to the offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective Investors in the United Kingdom </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">This document is for distribution only to persons who (i)&nbsp;have professional experience in matters relating to investments and who qualify
as investment professionals within the meaning of Article 19(5) of the Financial </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-35 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the &#147;Financial Promotion Order&#148;), (ii) are persons falling within Article 49(2)(a) to (d) (&#147;high net
worth companies, unincorporated associations etc.&#148;) of the Financial Promotion Order, (iii)&nbsp;are outside the United Kingdom, or (iv)&nbsp;are persons to whom an invitation or inducement to engage in investment activity (within the meaning
of Section&nbsp;21 of the Financial Services and Markets Act 2000, as amended (&#147;FSMA&#148;)) in connection with the issue or sale of any securities may otherwise lawfully be communicated or caused to be communicated (all such persons together
being referred to as &#147;relevant persons&#148;). This document is directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this document
relates is available only to relevant persons and will be engaged in only with relevant persons. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective Investors in Canada </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The shares of common stock may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors,
as defined in National Instrument <FONT STYLE="white-space:nowrap">45-106</FONT> Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National Instrument
<FONT STYLE="white-space:nowrap">31-103</FONT> Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the shares of common stock must be made in accordance with an exemption from, or in a transaction not subject to,
the prospectus requirements of applicable securities laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Securities legislation in certain provinces or territories of Canada may
provide a purchaser with remedies for rescission or damages if this prospectus supplement (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the
time limit prescribed by the securities legislation of the purchaser&#146;s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#146;s province or territory for particulars of
these rights or consult with a legal advisor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Pursuant to section 3A.3 of National Instrument
<FONT STYLE="white-space:nowrap">33-105</FONT> Underwriting Conflicts (NI <FONT STYLE="white-space:nowrap">33-105),</FONT> the underwriters are not required to comply with the disclosure requirements of NI
<FONT STYLE="white-space:nowrap">33-105</FONT> regarding underwriter conflicts of interest in connection with this offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective
Investors in Switzerland </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The shares may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange
(&#147;SIX&#148;) or on any other stock exchange or regulated trading facility in Switzerland. This document has been prepared without regard to the disclosure standards for issuance prospectuses under art. 652a or art. 1156 of the Swiss Code of
Obligations or the disclosure standards for listing prospectuses under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland. Neither this document nor any other offering
or marketing material relating to the shares or the offering may be publicly distributed or otherwise made publicly available in Switzerland. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Neither this document nor any other offering or marketing material relating to the offering, the Company, the shares have been or will be
filed with or approved by any Swiss regulatory authority. In particular, this document will not be filed with, and the offer of shares will not be supervised by, the Swiss Financial Market Supervisory Authority FINMA (FINMA), and the offer of shares
has not been and will not be authorized under the Swiss Federal Act on Collective Investment Schemes (&#147;CISA&#148;). The investor protection afforded to acquirers of interests in collective investment schemes under the CISA does not extend to
acquirers of shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective Investors in the Dubai International Financial Centre </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">This prospectus relates to an Exempt Offer in accordance with the Offered Securities Rules of the Dubai Financial Services Authority
(&#147;DFSA&#148;). This prospectus is intended for distribution only to persons of a type specified in the Offered Securities Rules of the DFSA. It must not be delivered to, or relied on by, any other person. The DFSA
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-36 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
has no responsibility for reviewing or verifying any documents in connection with Exempt Offers. The DFSA has not approved this prospectus nor taken steps to verify the information set forth
herein and has no responsibility for the prospectus. The shares to which this prospectus relates may be illiquid and/or subject to restrictions on their resale. Prospective purchasers of the shares offered should conduct their own due diligence on
the shares. If you do not understand the contents of this prospectus you should consult an authorized financial advisor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective
Investors in Australia </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">No placement document, prospectus, product disclosure statement or other disclosure document has been lodged
with the Australian Securities and Investments Commission (&#147;ASIC&#148;), in relation to the offering. This prospectus does not constitute a prospectus, product disclosure statement or other disclosure document under the Corporations Act 2001
(the &#147;Corporations Act&#148;), and does not purport to include the information required for a prospectus, product disclosure statement or other disclosure document under the Corporations Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Any offer in Australia of the shares may only be made to persons (the &#147;Exempt Investors&#148;) who are &#147;sophisticated
investors&#148; (within the meaning of section 708(8) of the Corporations Act), &#147;professional investors&#148; (within the meaning of section 708(11) of the Corporations Act) or otherwise pursuant to one or more exemptions contained in section
708 of the Corporations Act so that it is lawful to offer the shares without disclosure to investors under Chapter 6D of the Corporations Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The shares applied for by Exempt Investors in Australia must not be offered for sale in Australia in the period of 12 months after the date of
allotment under the offering, except in circumstances where disclosure to investors under Chapter 6D of the Corporations Act would not be required pursuant to an exemption under section 708 of the Corporations Act or otherwise or where the offer is
pursuant to a disclosure document which complies with Chapter 6D of the Corporations Act. Any person acquiring shares must observe such Australian <FONT STYLE="white-space:nowrap">on-sale</FONT> restrictions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">This prospectus contains general information only and does not take account of the investment objectives, financial situation or particular
needs of any particular person. It does not contain any securities recommendations or financial product advice. Before making an investment decision, investors need to consider whether the information in this prospectus is appropriate to their
needs, objectives and circumstances, and, if necessary, seek expert advice on those matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective Investors in Hong Kong </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The shares have not been offered or sold and will not be offered or sold in Hong Kong, by means of any document, other than (a)&nbsp;to
&#147;professional investors&#148; as defined in the Securities and Futures Ordinance (Cap. 571) of Hong Kong and any rules made under that Ordinance; or (b)&nbsp;in other circumstances which do not result in the document being a
&#147;prospectus&#148; as defined in the Companies Ordinance (Cap. 32) of Hong Kong or which do not constitute an offer to the public within the meaning of that Ordinance. No advertisement, invitation or document relating to the shares has been or
may be issued or has been or may be in the possession of any person for the purposes of issue, whether in Hong Kong or elsewhere, which is directed at, or the contents of which are likely to be accessed or read by, the public of Hong Kong (except if
permitted to do so under the securities laws of Hong Kong) other than with respect to the shares which are or are intended to be disposed of only to persons outside Hong Kong or only to &#147;professional investors&#148; as defined in the Securities
and Futures Ordinance and any rules made under that Ordinance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective Investors in Japan </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The shares have not been and will not be registered under the Financial Instruments and Exchange Law of Japan (Law No.&nbsp;25 of 1948, as
amended) and, accordingly, will not be offered or sold, directly or indirectly, in Japan, or for the benefit of any Japanese Person or to others for <FONT STYLE="white-space:nowrap">re-offering</FONT> or resale, directly or indirectly, in
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-37 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Japan or to any Japanese Person, except in compliance with all applicable laws, regulations and ministerial guidelines promulgated by relevant Japanese governmental or regulatory authorities in
effect at the relevant time. For the purposes of this paragraph, &#147;Japanese Person&#148; shall mean any person resident in Japan, including any corporation or other entity organized under the laws of Japan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><B><I>Singapore </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>Singapore SFA Product Classification&#151;In connection with Section 309B of the SFA and the CMP Regulations 2018, unless otherwise
specified before an offer of shares, the we have determined, and hereby notify all relevant persons (as defined in Section 309A(1) of the SFA), that the shares are &#145;&#145;prescribed capital markets products&#146;&#146; (as defined in the CMP
Regulations 2018) and Excluded Investment Products (as defined in MAS Notice SFA&nbsp;04-N12:&nbsp;Notice on the Sale of Investment Products and MAS Notice&nbsp;FAA-N16:&nbsp;Notice on Recommendations on Investment Products).</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Each representative has acknowledged that neither this prospectus supplement nor the accompanying prospectus has been registered as a
prospectus with the Monetary Authority of Singapore. Accordingly, each representative has represented and agreed that it has not offered or sold any shares or caused the shares to be made the subject of an invitation for subscription or purchase and
will not offer or sell any shares or cause the shares to be made the subject of an invitation for subscription or purchase, and has not circulated or distributed, nor will it circulate or distribute, this prospectus supplement or the accompanying
prospectus or any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the shares, whether directly or indirectly, to any person in Singapore other than: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to an institutional investor (as defined in Section 4A of the Securities and Futures Act (Chapter 289) of
Singapore, as modified or amended from time to time (the &#147;SFA&#148;)) pursuant to Section 274 of the SFA; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to a relevant person (as defined in Section 275(2) of the SFA) pursuant to Section 275(1) of the SFA and in
accordance with the conditions specified in&nbsp;Section&nbsp;275&nbsp;of&nbsp;the&nbsp;SFA; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA.
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Where the shares are subscribed or purchased under&nbsp;Section&nbsp;275&nbsp;of&nbsp;the&nbsp;SFA&nbsp;by a relevant person which is:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a corporation (which is not an accredited investor (as defined in Section 4A of the SFA)) the sole business of
which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each
beneficiary of the trust is an individual who is an accredited investor, securities or securities-based derivatives contracts (each term as defined in Section 2(1) of the SFA) of that corporation or the beneficiaries&#146; rights and interest
(howsoever described) in that trust shall not be transferred within six months after that corporation or that trust has acquired the shares pursuant to an offer made under&nbsp;Section&nbsp;275&nbsp;of&nbsp;the&nbsp;SFA&nbsp;except:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to an institutional investor or to a relevant person, or to any person arising from an offer referred to in
Section 276(4)(i)(B) of the SFA; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">where no consideration is or will be given for the transfer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">where the transfer is by operation of law; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">as specified in Section 276(7) of the SFA; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">as specified in Regulation 37A of the Securities and Futures (Offers of Investments) (Securities and
Securities-based Derivatives Contracts) Regulations 2018. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-38 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc32995_14"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The validity of the shares of common stock being offered by this prospectus supplement will be passed upon for us by K&amp;L Gates LLP,
Pittsburgh, Pennsylvania. Certain legal matters relating to this offering will be passed upon for the underwriters by Davis Polk&nbsp;&amp; Wardwell LLP, Menlo Park, California. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc32995_15"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements of <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated and Subsidiaries appearing in <FONT
STYLE="white-space:nowrap">II-VI&#146;s</FONT> Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> dated June&nbsp;29, 2020, and the effectiveness of <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated and Subsidiaries&#146;
internal control over financial reporting as of June&nbsp;30, 2019 (excluding the internal control over financial reporting of CoAdna Holdings, Inc. and Redstone Aerospace Corporation), have been audited by Ernst&nbsp;&amp; Young LLP, independent
registered public accounting firm, as set forth in their reports thereon, which as to the report on the effectiveness of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> internal control over financial reporting contains an explanatory paragraph
describing the above referenced exclusion of CoAdna Holdings, Inc. and Redstone Aerospace Corporation from the scope of such firm&#146;s audit of internal control over financial reporting, included therein, and incorporated herein by reference. Such
consolidated financial statements have been incorporated herein by reference in reliance upon such reports given on the authority of such firm as experts in accounting and auditing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements and schedule of Finisar Corporation as of April&nbsp;28, 2019 and April&nbsp;29, 2018 and for each of
the three years in the period ended April&nbsp;28, 2019, incorporated by reference in this prospectus supplement, have been so incorporated in reliance on the report of BDO USA, LLP, independent registered public accounting firm, incorporated herein
by reference, given on the authority of said firm as experts in auditing and accounting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc32995_16"></A>WHERE YOU CAN
FIND MORE INFORMATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We file annual, quarterly and special reports, proxy statements and other information with the SEC. You can
read our SEC filings, including the registration statement, at the SEC&#146;s website at www.sec.gov. Our web site is located at <FONT STYLE="white-space:nowrap">www.ii-vi.com.</FONT> The information contained on or accessible through our web site
is not part of this prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We will provide, upon written or oral request, without charge to you, including any beneficial
owner to whom this prospectus supplement is delivered, a copy of any or all of the documents incorporated herein by reference other than the exhibits to those documents, unless the exhibits are specifically incorporated by reference into the
information that this prospectus supplement incorporates. You should direct a request for copies to us at Attention: Secretary, 375 Saxonburg Boulevard, Saxonburg, PA 16056 or you may call us at
<FONT STYLE="white-space:nowrap">(724)&nbsp;352-4455.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-39 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc32995_17"></A><A NAME="supptoc32995_17"></A><A NAME="supptoc32995_17"></A>INCORPORATION BY REFERENCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">This prospectus supplement &#147;incorporates by reference&#148; certain information that we have filed with the SEC under the Securities
Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;). This means we are disclosing important information to you by referring you to those documents. We incorporate by reference the documents listed below and any future filings made by us
with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act until the offering is terminated: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000156459019032471/iivi-10k_20190630.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the fiscal year ended June&nbsp;30, 2019 filed with the SEC on August&nbsp;16, 2019; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Quarterly Report on <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000156459019042658/iivi-10q_20190930.htm">Form
 <FONT STYLE="white-space:nowrap">10-Q</FONT></A> for the quarter ended September&nbsp;30, 2019 filed with the SEC on November&nbsp;12, 2019; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Quarterly Report on <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000156459020004069/iivi-10q_20191231.htm">Form
 <FONT STYLE="white-space:nowrap">10-Q</FONT></A> for the quarter ended December&nbsp;31, 2019 filed with the SEC on February&nbsp;10, 2020; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Quarterly Report on <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000082031820000006/iivi-20200331.htm">Form
 <FONT STYLE="white-space:nowrap">10-Q</FONT></A> for the quarter ended March&nbsp;30, 2020 filed with the SEC on May&nbsp;11, 2020; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519189236/d732331d8k.htm">July
<U></U>&nbsp;3, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519191239/d768377d8k.htm">July<U></U>&nbsp;
9, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519202673/d778671d8k.htm">July<U></U>&nbsp;25, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519209907/d785268d8k.htm">August<U></U>&nbsp;1,
2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519219508/d780813d8k.htm">August<U></U>&nbsp;13, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519222521/d792454d8k.htm">August<U></U>&nbsp;
15, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519222891/d732685d8k.htm">August<U></U>&nbsp;16, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519226885/d786195d8k.htm">August<U></U>&nbsp;
22, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519232444/d767361d8k.htm">August<U></U>&nbsp;28, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519248114/d735094d8k.htm">September<U></U>&nbsp;
18, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519250134/d796902d8k.htm">September<U></U>&nbsp;
20, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519253627/d806984d8k.htm">September<U></U>&nbsp;
24, 2019</A> (as amended by the Current Reports on Form <FONT STYLE="white-space:nowrap">8-K/A</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519256345/d766725d8ka.htm">September<U></U>&nbsp;27, 2019</A>
and <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519309221/d843447d8ka.htm">December<U></U>&nbsp;9, 2019</A>), <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519272584/d822502d8k.htm">October<U></U>&nbsp;23,
2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519290146/d833367d8k.htm">November<U></U>&nbsp;12, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519304778/d836388d8k.htm">December<U></U>&nbsp;
3, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519326612/d862403d8k.htm">December<U></U>&nbsp;31, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312520019766/d878420d8k.htm">January<U></U>&nbsp;
30, 2020</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312520145328/d930712d8k.htm">May<U></U>&nbsp;19, 2020</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312520155799/d938285d8k.htm">May<U></U>&nbsp;29,
2020</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312520156545/d935912d8k.htm">June<U></U>&nbsp;
1, 2020</A>, and June 30, 2020 (<A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312520182949/d53753d8k.htm">I</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312520182942/d942419d8k.htm">II
</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312520182936/d931566d8k.htm">III</A>); </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the portions of our Definitive Proxy Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519261641/d791789ddef14a.htm">Schedule
 14A</A> filed on October&nbsp;
3, 2019 that are specifically incorporated by reference into our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000156459019032471/iivi-10k_20190630.htm">Form <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the fiscal
year ended June&nbsp;30, 2019; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Audited Consolidated Balance Sheets of Finisar as of April&nbsp;28, 2019 and April&nbsp;29, 2018 and the Audited
Consolidated Statements of Operations, Comprehensive Income (Loss), Stockholders&#146; Equity and Cash Flows of Finisar for the three years ended April&nbsp;28, 2019, April&nbsp;29, 2018 and April&nbsp;30, 2017, respectively, and related notes
(included in Finisar&#146;s Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1094739/000109473919000038/fnsr10kfy19.htm">Form <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the year ended April&nbsp;28, 2019 filed by Finisar
with the SEC on June&nbsp;14, 2019); </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Unaudited Condensed Consolidated Financial Statements of Finisar as of July&nbsp;28, 2019 (included in
Finisar&#146;s Quarterly Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1094739/000109473919000078/fnsr10qq1fy20.htm">Form <FONT STYLE="white-space:nowrap">10-Q</FONT></A> for the quarter ended July&nbsp;28, 2019 filed by Finisar with the
SEC on September&nbsp;4, 2019); and </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The description of the Company&#146;s Common Stock contained in our Registration Statement on Form 8-A filed
pursuant to Section 12(b) of the Exchange Act as filed with the SEC on September 14, 1987, including any subsequent amendments or reports filed for the purpose of updating such description. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">To the extent that any information contained in any report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> or <FONT
STYLE="white-space:nowrap">8-K/A,</FONT> or any exhibit thereto, was furnished to, rather than filed with, the SEC, such information or exhibit is specifically not incorporated by reference. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We have authorized no one to provide you with information other than information incorporated by reference or provided in this prospectus
supplement and the accompanying prospectus. You should not assume </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-40 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
that the information in this prospectus supplement or the accompanying prospectus is accurate as of any date other than the date on the front of this document. All documents that we file pursuant
to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this prospectus supplement or after the date of the registration statement of which this prospectus supplement and the accompanying prospectus forms a part and prior to the
termination of the offering will be deemed to be incorporated in this prospectus supplement by reference and will be a part of this prospectus supplement from the date of the filing of the document. Any statement contained in a document incorporated
or deemed to be incorporated by reference in this prospectus supplement will be deemed to be modified or superseded for purposes of this prospectus supplement to the extent that a statement contained in this prospectus supplement or in any other
subsequently filed document which also is or is deemed to be incorporated by reference in this prospectus supplement modifies or supersedes that statement. Any statement that is modified or superseded will not constitute a part of this prospectus
supplement, except as modified or superseded. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Requests for such copies should be directed to our Investor Relations department, at the
following address: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">375 Saxonburg Boulevard </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Saxonburg,
Pennsylvania 16056 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(724) <FONT STYLE="white-space:nowrap">352-4455</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-41 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Prospectus </B></P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g32717g82q21.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Preferred Stock </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may, from
time to time, offer to sell shares of common stock, no par value per share (&#147;Common Stock&#148;), or preferred stock, no par value per share (&#147;Preferred Stock&#148;), in one or more offerings. This prospectus describes some of the general
terms that may apply to such offerings. Each time we offer and sell shares of Common Stock or Preferred Stock, we will provide the specific terms in a supplement to this prospectus that contains specific information about such offering and the
amounts, prices and terms of the shares of Common Stock or Preferred Stock being offered in such offering. The supplement may also add, update or change information contained in this prospectus with respect to any such offering. You should read this
prospectus and any applicable prospectus supplement carefully before you invest in any shares of our Common Stock or Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
may offer and sell shares of Common Stock or Preferred Stock to or through one or more underwriters, dealers and agents or directly to purchasers, or through a combination of these methods, on a continuous or delayed basis. If any underwriters,
dealers or agents are involved in the sale of shares of Common Stock or Preferred Stock, an applicable prospectus supplement will set forth the applicable purchase price, fee, commissions or discounts between or among them. Our net proceeds from the
sale of Common Stock or Preferred Stock will be the public offering price less the applicable discount, in the case of an offering made through an underwriter, or the purchase price less the applicable commission, in the case of an offering through
an agent, and, in each case, less other expenses payable by us in connection with the issuance and distribution of such shares of Common Stock or Preferred Stock. See the sections of this prospectus entitled &#147;About this Prospectus&#148; and
&#147;Plan of Distribution&#148; for more information. No shares of Common Stock or Preferred Stock may be sold without delivery of this prospectus and an applicable prospectus supplement describing the method and terms of the offering of such
shares of Common Stock or Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may amend or supplement information contained in this prospectus from time to time. You
should carefully read this prospectus and any amendments or supplements before you invest in shares of our Common Stock or Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Common Stock is listed on The Nasdaq Global Select Market under the symbol &#147;IIVI.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>INVESTING IN OUR SECURITIES INVOLVES RISKS. SEE &#147;RISK&nbsp;FACTORS&#148; ON PAGE 6 OF THIS PROSPECTUS, AS WELL AS RISK FACTORS
DESCRIBED UNDER THE HEADING &#147;RISK&nbsp;FACTORS&#148; IN OUR MOST RECENT ANNUAL REPORT ON FORM <FONT STYLE="white-space:nowrap">10-K,</FONT> AS AMENDED, AND EACH SUBSEQUENT QUARTERLY REPORT ON FORM <FONT STYLE="white-space:nowrap">10-Q</FONT>
(WHICH DOCUMENTS ARE INCORPORATED BY REFERENCE HEREIN), BEFORE YOU INVEST IN SHARES OF OUR COMMON STOCK OR PREFERRED STOCK. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or
passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense. </B></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of this
prospectus is June&nbsp;30, 2020. </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc32717_1">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc32717_2">SPECIAL NOTE ABOUT FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc32717_3">TRADEMARKS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc32717_4">THE COMPANY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc32717_5">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc32717_6">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc32717_7">DIVIDEND POLICY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc32717_8">DESCRIPTION OF CAPITAL STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc32717_9">SELLING SECURITYHOLDERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc32717_10">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc32717_11">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc32717_12">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc32717_13">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc32717_14">INCORPORATION BY REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc32717_1"></A>ABOUT THIS PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus is part of a registration statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> that we filed with the United
States Securities and Exchange Commission (the &#147;SEC&#148;) utilizing a &#147;shelf&#148; registration process. Under this shelf process, we may from time to time sell shares of Common Stock or Preferred Stock as described in this prospectus in
one or more offerings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus provides you with a general description of the Common Stock and Preferred Stock we may offer. Each
time we sell securities pursuant to this prospectus, we will provide a prospectus supplement that will contain specific information about the terms of the offering. Such prospectus supplement may include a discussion of any risk factors or other
special consideration that apply to our securities and the offering. Such prospectus supplement may also add, update or change information contained in this prospectus. If there is any inconsistency between the information in this prospectus and a
prospectus supplement, you should rely on the information in that prospectus supplement. You should read both this prospectus and any applicable prospectus supplement together with additional information described above under the headings
&#147;Where You Can Find More Information&#148; and &#147;Incorporation by Reference.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">When acquiring any securities in an offering
pursuant to this prospectus, you should rely on the information provided in this prospectus and any applicable prospectus supplement, including the information incorporated by reference. Neither we, nor any underwriters or agents, have authorized
anyone to provide you with different information. We are not offering securities in any state where such an offer is prohibited. You should not assume that the information in this prospectus, any prospectus supplement, or any document incorporated
by reference, is truthful or complete at any date other than the date mentioned on the cover page of those documents. You should also carefully review the section entitled &#147;Risk Factors&#148;, which highlights certain risks associated with an
investment in our securities, to determine whether an investment in our Common Stock or other securities is appropriate for you. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">References in this prospectus to <FONT STYLE="white-space:nowrap">&#147;II-VI&#148;,</FONT> the &#147;Company&#148;, &#147;we&#148;,
&#147;us&#148; and &#147;our&#148; are to <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated and its subsidiaries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc32717_2"></A>SPECIAL NOTE ABOUT FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain information set forth in this prospectus or incorporated by reference in this prospectus may contain forward-looking statements within
the meaning of Section&nbsp;27A of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), and Section&nbsp;21E of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), that are intended to be covered by
the &#147;safe harbor&#148; created by those sections. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms
such as &#147;believe,&#148; &#147;expect,&#148; &#147;may,&#148; &#147;will,&#148; &#147;should,&#148; &#147;would,&#148; &#147;could,&#148; &#147;seek,&#148; &#147;intend,&#148; &#147;plan,&#148; &#147;estimate,&#148; &#147;goal,&#148;
&#147;anticipate,&#148; &#147;project&#148; or other comparable terms. All statements other than statements of historical facts included in this prospectus regarding our strategies, prospects, expectations, financial condition, operations, costs,
plans and objectives are forward-looking statements. Examples of forward-looking statements include, among others, statements we make regarding expected future operating results, anticipated results of our sales and marketing efforts, and
anticipated benefits resulting from completed acquisitions. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the
future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and
changes in circumstances that are difficult to predict and many of which are outside of our control. Important factors that could cause actual results, conditions and events to differ materially from those indicated in the forward-looking statements
include, among others, the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">uncertainties associated with the coronavirus <FONT STYLE="white-space:nowrap">(COVID-19)</FONT> pandemic,
including its possible effects on our operations, liquidity, financial condition, supply chain and personnel, and the demand for our products and services; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">investments in future markets of potential significant growth may not result in the expected return;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the possibility that the anticipated benefits from completed acquisitions, including, but not limited to, our
combination with Finisar Corporation (&#147;Finisar&#148;), cannot be realized in full or at all or may take longer to realize than expected; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to develop new products and processes; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">global economic downturns, including any downturn related to <FONT STYLE="white-space:nowrap">COVID-19,</FONT>
which may adversely affect our business, operating results and financial condition; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">some systems that use our products which are complex in design, and products of ours that may contain defects
that are not detected until deployed, which could increase our costs, reduce our revenues, cause us to lose key customers and may expose us to litigation arising from derivative lawsuits related to consumer products; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">foreign currency risk which may negatively affect our revenues, cost of sales and operating margins and could
result in foreign exchange losses; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to retain our competitive position, which may require significant investments; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our inability to successfully implement our acquisitions strategy or integrate acquired companies and personnel
with existing operations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our future success being dependent on continued international sales, and the fact that our global operations are
complex and present multiple challenges to manage; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">complex and rapidly changing governmental import and export regulations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in U.S. trade policies, particularly with respect to China and to companies on the U.S. Entity List, such
as Huawei, could impact our international operations and the cost of goods imported into the United States, which may narrow the size of our markets, materially impact our revenues or increase our operating costs and expose us to contract
litigation; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to settle conversions of our convertible senior notes in cash or to repurchase such notes in
accordance with their terms; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our failure to accurately estimate the size and growth of our markets and our customers&#146; demands;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">increased competition; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">limitations on the protection of our intellectual property, and our involvement from time to time in costly
intellectual property litigation or indemnification; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a significant portion of our business being dependent on cyclical industries; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our global operations being subject to complex legal and regulatory requirements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in laws and regulations governing data privacy and data protection that could have a material adverse
impact on our business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">data breach incidents and breakdown of information and communication technologies that could disrupt our
operations and impact our financial results; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our entry into supply agreements which commit us to supply products on specified terms; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our dependence on highly complex manufacturing processes that require feeder materials, components and products
from limited sources of supply; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">increases in commodity prices that may adversely affect our results of operations and financial condition;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our use and generation of potentially hazardous substances that are subject to stringent environmental
regulations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">unfavorable changes in tax rates, tax liabilities or tax accounting rules that could negatively affect future
results; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">natural disasters or other global or regional catastrophic events that could disrupt our operations, give rise to
substantial environmental hazards and adversely affect our results; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to attract, retain and develop key personnel and need for continued good relations with our
employees; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our stock price, which has been volatile in the past and may be volatile in the future; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">some anti-takeover provisions contained in our Amended and Restated Articles of Incorporation (the &#147;Articles
of Incorporation&#148;) and Amended and Restated By-Laws (the &#147;By-Laws&#148;), as well as provisions of Pennsylvania law, which could impair a takeover attempt and also reduce the market price of our Common Stock or other securities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">because we do not currently intend to pay dividends, holders of our Common Stock will benefit from an investment
in our Common Stock only if it appreciates in value, and by the intended anti-dilution actions of our share-buyback program; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our contracts with a number of large <FONT STYLE="white-space:nowrap">end-user</FONT> service providers and
product companies that have considerable bargaining power, which may require us to agree to terms and conditions that could have an adverse effect on our business or ability to recognize revenues; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">climate change regulations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our dependence on large purchases from a few significant customers, and any loss, cancellation, reduction or
delay in purchases by these customers which could harm our business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the manufacturing of our products which may be adversely affected if we are unable to manufacture certain
products in our manufacturing facilities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our failure to accurately forecast our revenues which could result in additional charges for obsolete or excess
inventories or <FONT STYLE="white-space:nowrap">non-cancelable</FONT> purchase commitments; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our failure to maintain an effective system of disclosure controls and internal control over financial reporting,
which could impair our ability to produce timely and accurate financial statements or comply with applicable regulations; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">those risks and uncertainties described in the documents incorporated by reference into this prospectus.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Therefore, you should not rely on any of these forward-looking statements. We urge you to consider those risks and
uncertainties in evaluating our forward-looking statements. All subsequent written and oral forward-looking statements attributable to us or to persons acting on our behalf are expressly qualified in their entirety by the applicable cautionary
statements. We further caution readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Except as otherwise required by the federal securities laws, we undertake no obligation to publicly
update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc32717_3"></A>TRADEMARKS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have proprietary rights to trademarks used in the information incorporated by reference into this prospectus, which are important to our
business, many of which are registered under applicable intellectual property laws. Solely for convenience, trademarks and trade names referred to in the information incorporated by reference in this prospectus may appear without the &#147;<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>&#148; or &#147;<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP>&#148; symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest
extent possible under applicable law, our rights or the rights of the applicable licensor to these trademarks and trade names. We do not intend our use or display of other companies&#146; trade names, trademarks or service marks to imply a
relationship with, or endorsement or sponsorship of us by, any other companies. Each trademark, trade name or service mark of any other company appearing in this prospectus is the property of its respective holder. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc32717_4"></A>THE COMPANY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>This summary highlights selected information contained elsewhere, or incorporated by reference, in this prospectus. This summary does not
contain all of the information that you should consider before deciding to invest in our securities. You should carefully read the entire prospectus, any accompanying prospectus supplement and any related free writing prospectus, including the risks
of investing in our securities discussed under the heading &#147;Risk Factors&#148; contained herein and in any accompanying prospectus supplement and any related free writing prospectus, and under a similar heading in other documents that are
incorporated by reference into this prospectus. You also should carefully read the information incorporated by reference into this prospectus, including our financial statements and the exhibits to the registration statement of which this prospectus
is a part. Unless the context otherwise requires, <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated is referred to herein, collectively with all of its subsidiaries, as the &#147;Company&#148;,
<FONT STYLE="white-space:nowrap">&#147;II-VI&#148;,</FONT> or &#147;we&#148;, &#147;us&#148;, or &#147;our&#148;. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated, a worldwide leader in engineered materials and optoelectronic components, is a
vertically integrated manufacturing company that develops innovative products for industrial materials processing, communications, aerospace and defense, consumer electronics, semiconductor capital equipment, life sciences and automotive end
markets. On September&nbsp;24, 2019, we completed our acquisition of Finisar, a global technology leader for subsystems and components for fiber optic communications. We believe that our combination with Finisar will help make us a global leader in
optical communications while continuing our leadership in other end markets. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We develop, manufacture, and market engineered materials, optoelectronic components, and
devices for precision use in industrial materials processing, optical communications, aerospace and defense, consumer electronics, semiconductor capital equipment, life sciences, and automotive applications and markets. We use advanced engineered
materials growth technologies coupled with proprietary high-precision fabrication, microassembly, optical thin-film coating, and electronic integration to manufacture complex optoelectronic devices and modules. Our products are deployed in a variety
of applications, including (i)&nbsp;laser cutting, welding, and marking operations; (ii)&nbsp;3D sensing consumer applications; (iii)&nbsp;optical, data, and wireless communications products; (iv)&nbsp;strategic aerospace and defense applications
including intelligence, surveillance, and reconnaissance; (v)&nbsp;semiconductor processing and tooling; and (vi)&nbsp;thermoelectric cooling and power-generation solutions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Through research, development and engineering (RD&amp;E) and acquisitions, we have expanded our portfolio of materials. We believe that the
materials we grow and fabricate are differentiated by one or a combination of unique optical, electrical, thermal, and mechanical properties. Our optics are shaped by precision surfacing techniques to meet the most stringent requirements for flat or
curved geometries, functionalized with smooth or structured surfaces, or with patterned metallization. Proprietary processes developed at our global optical coating centers differentiate our products&#146; durability against high-energy lasers and
extreme operating environments. Optical coatings also provide the desired spectral characteristics ranging from the ultraviolet to the <FONT STYLE="white-space:nowrap">far-infrared.</FONT> We leverage these capabilities to deliver miniature- to
large-scale precision optical assemblies, including those in combination with thermal management components, integrated electronics, and/or software. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We also offer a broad portfolio of compound semiconductor lasers that are used in a variety of applications in most of our end markets. These
compound semiconductor lasers enable high-power lasers for materials processing; optical signal amplification in terrestrial and submarine communications networks;
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">high-bit-rate</FONT></FONT> server connectivity between and within datacenters; and fast and accurate measurements in biomedical instruments, consumer electronics, and optical
communications network monitoring. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We generate revenues, earnings and cash flows from developing, manufacturing and marketing a broad
portfolio of products for our end markets. We also generate revenue, earnings and cash flows from government-funded research and development contracts relating to the development and manufacture of new technologies, materials and products. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our customer base includes original equipment manufacturers, laser end users, system integrators of high-power lasers, manufacturers of
equipment and devices for industrial, optical communications, consumer electronics, security and monitoring applications, U.S. government prime contractors, and various U.S. government agencies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are headquartered in Saxonburg, Pennsylvania, with RD&amp;E, manufacturing, and sales facilities worldwide. Our U.S. production and
research and development operations are located in Pennsylvania, California, New Jersey, Texas, Mississippi, Massachusetts, Connecticut, Delaware, New York, Florida, Ohio, Arizona, Colorado, and Illinois, and our
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> production operations are based in China, Singapore, Vietnam, the Philippines, Germany, Switzerland, and the United Kingdom. We also utilize contract manufacturers and strategic suppliers. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Company Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We were incorporated
in the Commonwealth of Pennsylvania on June&nbsp;22, 1971. Our corporate headquarters are located at 375 Saxonburg Boulevard, Saxonburg, Pennsylvania 16056. Our telephone number is (724) <FONT STYLE="white-space:nowrap">352-4455.</FONT> Our Internet
website address is <FONT STYLE="white-space:nowrap">www.ii-vi.com.</FONT> The information contained on, or that can be accessed through, our website is deemed not to be incorporated in this prospectus or to be part of this prospectus. Our name is
pronounced &#147;Two Six Incorporated,&#148; which refers to Groups II and VI on the periodic table of elements from which we originally designed and produced infrared optics for high-power carbon dioxide lasers used in materials processing. You can
obtain additional information regarding our business by reading our Annual </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for our most recent fiscal year ended June&nbsp;30, 2019, our subsequently filed Quarterly Reports on
<FONT STYLE="white-space:nowrap">Form&nbsp;10-Q</FONT> and the other reports we file with the SEC. See &#147;Where You Can Find More Information.&#148; </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc32717_5"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Investing in our securities involves risk. See the risk factors described in our Annual Report on
<FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> for our most recent fiscal year (together with any material changes thereto contained in subsequent filed Quarterly Reports on <FONT STYLE="white-space:nowrap">Form&nbsp;10-Q)</FONT> and those
contained in our other filings with the SEC, which are incorporated by reference in this prospectus and any accompanying prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to making a decision about investing in our securities, you should carefully consider the specific factors discussed under the caption
&#147;Risk Factors&#148; in any applicable prospectus supplement, together with all of the other information contained in any applicable prospectus supplement or appearing or incorporated by reference in this prospectus. These risks could materially
affect our business, results of operations or financial condition and cause the value of our securities to decline. You could lose all or part of your investment. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc32717_6"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We intend to use the net proceeds from the sale of securities pursuant to this prospectus as set forth in any applicable prospectus
supplement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc32717_7"></A>DIVIDEND POLICY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have never paid cash dividends on our Common Stock and do not anticipate paying any cash dividends in the foreseeable future. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc32717_8"></A>DESCRIPTION OF CAPITAL STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following summary description of our capital stock is based on the provisions of our Articles of Incorporation, our <FONT
STYLE="white-space:nowrap">By-Laws</FONT> and the applicable provisions of the Pennsylvania Business Corporation Law (the &#147;BCL&#148;). This information may not be complete in all respects and is qualified entirely by reference to the provisions
of our Articles of Incorporation, <FONT STYLE="white-space:nowrap">By-Laws</FONT> and the BCL. For information on how to obtain copies of our Articles of Incorporation and <FONT STYLE="white-space:nowrap">By-Laws,</FONT> see the discussion above
under the heading &#147;Where You Can Find More Information.&#148; As of the date of this prospectus, our authorized capital stock consists of 300,000,000 shares of Common Stock and 5,000,000 shares of Preferred Stock. As of March&nbsp;31, 2020,
91,175,715 shares of Common Stock were outstanding and no shares of Preferred Stock were outstanding. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may offer shares of Common Stock, including shares of Common Stock issuable upon the conversion of Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Voting Rights </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each outstanding share of our Common Stock is entitled to one vote on all matters submitted to a vote of shareholders. There is no cumulative
voting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Dividend and Liquidation Rights </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of outstanding shares of our Common Stock are entitled to receive dividends out of assets legally available for the payment of
dividends at the times and in the amounts as our Board of Directors may from time to time determine. Holders of our Common Stock have no preemptive or subscription rights to purchase any of our securities and no sinking fund provisions apply to our
Common Stock. Upon the liquidation, dissolution or winding up of the Company, the holders of our Common Stock are entitled to receive pro rata the assets of the Company which are legally available for distribution, after payment of all debts and
other liabilities and subject to the prior rights of any holders of Preferred Stock then outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have never paid any cash
dividends on our Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Fully Paid and <FONT STYLE="white-space:nowrap">Non-Assessable</FONT> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All outstanding shares of our Common Stock are fully paid and <FONT STYLE="white-space:nowrap">non-assessable.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Nasdaq Listing </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Common Stock is listed on The Nasdaq Global Select Market under the symbol &#147;IIVI.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Transfer Agent and Registrar </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The transfer agent and registrar for our Common Stock is American Stock Transfer and Trust Company,&nbsp;LLC. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preferred Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Articles
of Incorporation, our Board of Directors has the authority, without further action by our shareholders, to issue from time to time up to 5,000,000 shares of Preferred Stock in one or more series. Our Board of Directors may designate the rights,
preferences, privileges, and restrictions of the Preferred Stock, including dividend rights, conversion rights, voting rights, redemption rights, liquidation preference, sinking fund terms, and the number of shares constituting any series or the
designation of any series. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The issuance of Preferred Stock could have the effect of restricting dividends on the Common Stock, diluting
the voting power of the Common Stock, impairing the liquidation rights of the Common Stock, or delaying, deterring, or preventing a change in control. Such issuance could have the effect of decreasing the market price of the Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The particular terms of any series of Preferred Stock being offered by us under this prospectus will be described in the prospectus supplement
relating to that series of preferred stock. Those terms may include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the title and liquidation preference per share of the Preferred Stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number of shares of Preferred Stock offered; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the purchase price of the Preferred Stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the dividend rate (or method of calculation), the dates on which dividends will be paid and the date from which
dividends will begin to accumulate; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any redemption or sinking fund provisions of the Preferred Stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any conversion provisions of the Preferred Stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the voting rights, if any, of the Preferred Stock; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any additional dividend, liquidation, redemption, sinking fund and other rights, preferences, privileges,
limitations and restrictions of the Preferred Stock. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the terms of any series of Preferred Stock being offered differ from the terms set forth
in this prospectus, the definitive terms will be disclosed in the applicable prospectus supplement. The summary in this prospectus is not complete. You should refer to the applicable Articles of Amendment to our Articles of Incorporation or
Statement with Respect to Shares, as the case may be, establishing a particular series of Preferred Stock, in either case which will be filed with the Secretary of State of the Commonwealth of Pennsylvania and the SEC in connection with an offering
of Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Preferred Stock will, when issued, be fully paid and nonassessable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Dividend Rights </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as indicated in the applicable prospectus supplement, the Preferred Stock will be preferred over our Common Stock as to payment of
dividends. Before any dividends or distributions (other than dividends or distributions payable in Common Stock) on our Common Stock will be declared and set apart for payment or paid, the holders of shares of each series of Preferred Stock will be
entitled to receive dividends when, as and if declared by our Board of Directors. Subject to the limitations of Pennsylvania law, we will pay those dividends either in cash, shares of Common Stock or Preferred Stock or otherwise, at the rate and on
the date or dates set forth in the applicable prospectus supplement. With respect to each series of Preferred Stock, the dividends on each share of the series will be cumulative from the date of issue of the share unless another date is set forth in
the applicable prospectus supplement relating to the series. Accruals of dividends will not bear interest. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Rights upon Liquidation
</I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as indicated in the applicable prospectus supplement, the Preferred Stock will be preferred over our Common Stock as to
assets so that the holders of any series of Preferred Stock will be entitled to be paid, upon our voluntary or involuntary liquidation, dissolution or winding up and before any distribution is made to the holders of Common Stock, the amount set
forth in the applicable prospectus supplement. In this case, however, the holders of Preferred Stock will not be entitled to any other or further payment. If upon any liquidation, dissolution or winding up our net assets are insufficient to permit
the payment in full of the respective amounts to which the holders of all outstanding Preferred Stock are entitled, our entire remaining net assets will be distributed among the holders of each series of Preferred Stock in amounts proportional to
the full amounts to which the holders of each series are entitled. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Redemption </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All shares of any series of Preferred Stock will be redeemable to the extent set forth in the prospectus supplement relating to the series and
as allowed by Pennsylvania law. All shares of any series of Preferred Stock will be convertible into shares of our Common Stock or into shares of any other series of our Preferred Stock to the extent set forth in the applicable prospectus
supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Voting Rights </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as indicated in the applicable prospectus supplement, the holders of Preferred Stock will not be entitled to vote with respect to
shares of Preferred Stock held by then on matters properly presented to shareholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Additional Series of Preferred Stock
</I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board of Directors has the authority, without further action by our shareholders, to issue from time to time additional
shares of Preferred Stock in one or more series and to designate the rights, preferences, privileges, and restrictions of such Preferred Stock. This authority may be limited by applicable law, our Articles of Incorporation, as it may amended or
further restated from time to time, including pursuant to the terms of any existing series of Preferred Stock, and the applicable rules of the stock exchanges upon which the Common Stock is listed. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Anti-Takeover Law Provisions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain provisions of Pennsylvania law and our Articles of Incorporation and our <FONT STYLE="white-space:nowrap">By-Laws</FONT> could make the
acquisition of the Company by means of a tender offer, or the acquisition of control of the Company by means of a proxy contest or otherwise, more difficult. These provisions, summarized below, are intended to discourage certain types of coercive
takeover practices and inadequate takeover bids, and are designed to encourage persons seeking to acquire control of the Company to negotiate with our board of directors. We believe that the benefits of increased protection against an unfriendly or
unsolicited proposal to acquire or restructure the Company outweigh the disadvantages of discouraging such proposals. Among other things, negotiation of such proposals could result in an improvement of their terms. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Pennsylvania State Law Provisions </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are subject to various anti-takeover provisions of the BCL. Many of these provisions are triggered if any person or group acquires, or
discloses intent to acquire, 20% or more of a Pennsylvania corporation&#146;s voting power, subject to certain exceptions. These provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provide the other shareholders of the corporation with certain rights against the acquiring group or person;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prohibit the corporation from engaging in a broad range of business combinations with the acquiring group or
person; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prohibit the corporation from engaging in a broad range of business combinations with the acquiring group or
person; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">restrict the voting and other rights of the acquiring group or person; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provide that certain profits realized by the acquiring group or person from the sale of a corporation&#146;s
equity securities belong to and are recoverable by the corporation. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Regardless of the amount of a person&#146;s
holdings, if a shareholder or shareholder group (including affiliated persons) would be a party to certain proposed transactions with the Company or would be treated differently from our other shareholders in certain proposed transactions, the BCL
requires approval by a majority of votes entitled to be cast by all shareholders other than the interested shareholder or affiliate group, unless the transaction is approved by independent directors or other criteria are satisfied. Furthermore,
under Pennsylvania law, a &#147;short-form&#148; merger of the Company cannot be implemented without the consent of our board of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, as permitted by Pennsylvania law, an amendment to our Articles of Incorporation or other corporate action that is approved by
shareholders may provide mandatory special treatment for specified groups of <FONT STYLE="white-space:nowrap">non-consenting</FONT> shareholders of the same class. For example, an amendment to our Articles of Incorporation or other corporate action
may provide that shares of our Common Stock held by designated shareholders of record must be cashed out at a price determined by us, subject to applicable dissenters&#146; rights. In these cases, Pennsylvania law requires either a special class
vote or dissenters&#146; rights for holders of the group designated for special treatment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, the BCL provides that directors
may, in discharging their duties, consider, to the extent they deem appropriate, the effects of any action upon shareholders, employees, suppliers, customers and the communities in which its offices are located. Directors are not required to
consider the interests of shareholders to a greater degree than other constituencies&#146; interests. The BCL expressly provides that the fiduciary duty of directors does not require the directors to redeem or modify any &#147;poison pills&#148; or
take action under the anti-takeover provisions of the BCL in order to allow or facilitate a potential change of control. We do not currently have a &#147;poison pill.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Other Provisions in our Articles of Incorporation and our
<FONT STYLE="white-space:nowrap">By-Laws</FONT> </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Articles of Incorporation and our <FONT STYLE="white-space:nowrap">By-Laws</FONT>
contain provisions that could make us a less attractive target for a hostile takeover and could make more difficult or discourage a merger proposal, a tender offer or a proxy contest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Such provisions include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a requirement that shareholder-nominated director nominees be nominated in advance of the meeting at which
directors are elected and that specific information be provided in connection with such nomination; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability of our board of directors to issue additional shares of Common Stock or Preferred Stock without
shareholder approval; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain provisions requiring supermajority approval (at least <FONT STYLE="white-space:nowrap">two-thirds</FONT>
of the votes cast by all shareholders entitled to vote thereon, voting together as a single class). </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Indemnification Of Directors And
Executive Officers And Limitation On Liability. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Pennsylvania Business Corporation Law </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sections 1741 and 1742 of the BCL provide that a business corporation shall have the power to indemnify any person who was or is a party, or is
threatened to be made a party, to any proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that such person is or was a director, officer, employee or agent of the corporation, or is or was serving at the
request of the corporation as a director, officer, employee or agent of another corporation or other enterprise, against expenses (including attorneys&#146; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by
such person in connection with such proceeding, if such person acted in good faith and in a manner he reasonably believed to be in, or not opposed to, the best interests of the corporation, and, with respect to any criminal proceeding, had no
reasonable cause to believe his conduct was unlawful. In the case of an action by or in the right of the corporation, such indemnification is limited to expenses (including attorneys&#146; fees) actually and reasonably incurred by such person in
connection with the defense or settlement of such action, except that no indemnification shall be made in respect of any claim, issue or matter as to which such person has been adjudged to be liable to the corporation unless, and only to the extent
that, a court determines upon application that, despite the adjudication of liability but in view of all the circumstances, such person is fairly and reasonably entitled to indemnity for the expenses that the court deems proper. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">BCL Section&nbsp;1744 provides that, unless ordered by a court, any indemnification referred to above shall be made by the corporation only as
authorized in the specific case upon a determination that indemnification is proper in the circumstances because the indemnitee has met the applicable standard of conduct. Such determination shall be made: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by the Board of Directors by a majority vote of a quorum consisting of directors who were not parties to the
proceeding; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if such a quorum is not obtainable, or if obtainable and a majority vote of a quorum of disinterested directors
so directs, by independent legal counsel in a written opinion; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by the shareholders. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the above, BCL Section&nbsp;1743 provides that to the extent that a director, officer, employee or agent of a business
corporation is successful on the merits or otherwise in defense of any proceeding referred to in BCL Section&nbsp;1741 or 1742, or in defense of any claim, issue or matter therein, such person shall be indemnified against expenses (including
attorneys&#146; fees) actually and reasonably incurred by such person in connection therewith. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">BCL Section&nbsp;1745 provides that expenses (including attorneys&#146; fees) incurred by an
officer, director, employee or agent of a business corporation in defending any proceeding may be paid by the corporation in advance of the final disposition of the proceeding upon receipt of an undertaking by the indemnitee to repay the amount
advanced if it is ultimately determined that the indemnitee is not entitled to be indemnified by the corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">BCL Section&nbsp;1746
provides that the indemnification and advancement of expenses provided by, or granted pursuant to, the foregoing provisions is not exclusive of any other rights to which a person seeking indemnification or advancement of expenses may be entitled
under any bylaw, agreement, vote of shareholders or disinterested directors or otherwise, and that indemnification may be granted under any bylaw, agreement, vote of shareholders or disinterested directors or otherwise for any action taken or any
failure to take any action whether or not the corporation would have the power to indemnify the person under any other provision of law and whether or not the indemnified liability arises or arose from any action by or in the right of the
corporation, provided, however, that no indemnification may be made in any case where the act or failure to act giving rise to the claim for indemnification is determined by a court to have constituted willful misconduct or recklessness. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">BCL Section&nbsp;1747 permits a Pennsylvania business corporation to purchase and maintain insurance on behalf of any person who is or was a
director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation or other enterprise, against any liability asserted against such person
and incurred by such person in any such capacity, or arising out of such person&#146;s status as such, whether or not the corporation would have the power to indemnify the person against such liability under the provisions described above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">BCL Sections 1748 and 1749 extend the indemnification and advancement of expenses provisions to successor corporations in consolidations,
mergers or divisions and to representatives serving as fiduciaries of employee benefit plans. BCL Section&nbsp;1750 provides that the indemnification and advancement of expenses provided by, or granted pursuant to, Subchapter E of the BCL, shall,
unless otherwise provided when authorized or ratified, continue as to a person who has ceased to be a representative of the corporation and shall inure to the benefit of the heirs and personal representative of such person. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">By-Laws</FONT> </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Article VI of our <FONT STYLE="white-space:nowrap">By-Laws</FONT> provides that the directors and officers of the registrant shall be
indemnified to the fullest extent not prohibited by law in connection with any actual or threatened action, suit or proceeding, civil, criminal, administrative, investigative or other (whether brought by or in the right of the registrant or
otherwise) arising out of their service to the registrant or to another corporation, partnership, joint venture, trust or other enterprise at the request of the registrant, with certain limitations and exceptions. Article VI of our <FONT
STYLE="white-space:nowrap">By-Laws</FONT> also provides that our employees and agents who are not directors or officers may be indemnified with such scope and effect as determined by the registrant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Article VI of our <FONT STYLE="white-space:nowrap">By-Laws</FONT> also provides that we may purchase and maintain insurance to protect itself
and any director, officer, agent or employee against any liability asserted against and incurred by him or her in respect of such service, whether or not the registrant would have the power to indemnify him or her against such liability by law or
under the provisions of the <FONT STYLE="white-space:nowrap">By-Laws.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As permitted by BCL Section&nbsp;1713, our <FONT
STYLE="white-space:nowrap">By-Laws</FONT> provide that directors shall not be personally liable to the registrant for monetary damages for any action taken, or any failure to take any action, unless, (A)&nbsp;the director has breached or failed to
perform the duties of his/her office under certain provisions of the <FONT STYLE="white-space:nowrap">By-Laws</FONT> relating to standard of care and justifiable reliance; and (B)&nbsp;the breach or failure to perform constitutes self-dealing,
willful misconduct or recklessness. The BCL states that this exculpation from liability does not apply to the responsibility or liability of a director pursuant to any criminal statute or the liability of a director for the payment of taxes pursuant
to federal, state or local law. It may also not apply to liabilities imposed upon directors </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
by the Federal securities laws. BCL Section&nbsp;1715(d) creates a presumption, subject to exceptions, that a director acted in the best interests of the corporation. BCL Section&nbsp;1712, in
defining the standard of care a director owes to the corporation, provides that a director stands in a fiduciary relation to the corporation and must perform his duties as a director or as a member of any committee of the Board of Directors in good
faith, in a manner he reasonably believes to be in the best interests of the corporation and with such care, including reasonable inquiry, skill and diligence, as a person of ordinary prudence would use under similar circumstances. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Director and Officer Liability Insurance </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We maintain directors&#146; and officers&#146; liability insurance covering our directors and officers with respect to liability which they may
incur in connection with their serving as such, which liability could include liability under the Securities Act. Under the insurance, we are entitled to reimbursement for amounts as to which the directors and officers are indemnified under the
indemnification provisions of our <FONT STYLE="white-space:nowrap">By-Laws.</FONT> The insurance may also provide certain additional coverage for the directors and officers against certain liability even though such liability is not subject to the
indemnification provisions of our <FONT STYLE="white-space:nowrap">By-Laws.</FONT> </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc32717_9"></A>SELLING SECURITYHOLDERS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Information about selling securityholders, where applicable, will be set forth in a prospectus supplement, in a post-effective
amendment or in filings we make with the SEC which are incorporated by reference into this prospectus. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc32717_10"></A>PLAN
OF DISTRIBUTION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may sell the securities offered by this prospectus to one or more underwriters or dealers for public offering,
through agents, directly to purchasers or through a combination of any such methods of sale. The name of any such underwriters, dealers or agents involved in the offer and sale of the securities, the amounts underwritten and the nature of its
obligation to take the securities will be specified in any applicable prospectus supplement. We have reserved the right to sell the securities directly to investors on our own behalf in those jurisdictions where we are authorized to do so. The sale
of the securities may be effected in transactions (a)&nbsp;on any national or international securities exchange or quotation service on which the securities may be listed or quoted at the time of sale, (b)&nbsp;in the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market, (c)&nbsp;in transactions otherwise than on such exchanges or in the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market or (d)&nbsp;through the writing of options. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We and our agents and underwriters may offer and sell the securities at a fixed price or prices that may be changed, at market prices
prevailing at the time of sale, at prices related to such prevailing market prices or at negotiated prices. The securities may be offered on an exchange, which will be disclosed in any applicable prospectus supplement. We may, from time to time,
authorize dealers, acting as our agents, to offer and sell the securities upon such terms and conditions as set forth in any applicable prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may enter into agreements with underwriters to sell our securities. In connection with the sale of the securities, underwriters may receive
compensation from us in the form of underwriting discounts or commissions and may also receive commissions from purchasers of the securities for whom they may act as agent. Any underwriting compensation paid by us to underwriters or agents in
connection with the offering of the securities, and any discounts, concessions or commissions allowed by underwriters to participating dealers, will be set forth in any applicable prospectus supplement to the extent required by applicable law.
Underwriters may sell the securities to or through dealers, and such dealers may receive compensation in the form of discounts, concessions or commissions from the underwriters or commissions (which may be changed from time to time) from the
purchasers for whom they may act as agents. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dealers and agents participating in the distribution of the securities may be deemed to be
underwriters, and any discounts and commissions received by them and any profit realized by them on resale of the securities may be deemed to be underwriting discounts and commissions under the Securities Act. Unless otherwise indicated in any
applicable prospectus supplement, an agent will be acting on a best efforts basis and a dealer will purchase debt securities as a principal, and may then resell the debt securities at varying prices to be determined by the dealer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If so indicated in any prospectus supplement, we will authorize underwriters, dealers or agents to solicit offers by certain specified
institutions to purchase offered securities from us at the public offering price set forth in such prospectus supplement pursuant to delayed delivery contracts providing for payment and delivery on a specified date in the future. Such contracts will
be subject to any conditions set forth in any applicable prospectus supplement and such prospectus supplement will set forth the commission payable for solicitation of such contracts. The underwriters and other persons soliciting such contracts will
have no responsibility for the validity or performance of any such contracts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Underwriters, dealers and agents may be entitled, under
agreements entered into with us, to indemnification against and contribution towards certain civil liabilities, including any liabilities under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To facilitate the offering of securities, certain persons participating in the offering may engage in transactions that stabilize, maintain,
or otherwise affect the price of the securities. These may include over-allotment, stabilization, syndicate short covering transactions and penalty bids. Over-allotment involves sales in excess of the offering size, which creates a short position.
Stabilizing transactions involve bids to purchase the underlying security so long as the stabilizing bids do not exceed a specified maximum. Syndicate short covering transactions involve purchases of securities in the open market after the
distribution has been completed in order to cover syndicate short positions. Penalty bids permit the underwriters to reclaim selling concessions from dealers when the securities originally sold by the dealers are purchased in covering transactions
to cover syndicate short positions. These transactions may cause the price of the securities sold in an offering to be higher than it would otherwise be. These transactions, if commenced, may be discontinued by the underwriters at any time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any securities other than our Common Stock issued hereunder may be new issues of securities with no established trading market. Any
underwriters or agents to or through whom such securities are sold for public offering and sale may make a market in such securities, but such underwriters or agents will not be obligated to do so and may discontinue any market making at any time
without notice. No assurance can be given as to the liquidity of the trading market for any such securities. The amount of expenses expected to be incurred by us in connection with any issuance of securities will be set forth in any applicable
prospectus supplement. Certain of the underwriters, dealers or agents and their associates may engage in transactions with, and perform services for, us and certain of our affiliates in the ordinary course of business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During such time as we may be engaged in a distribution of the securities covered by this prospectus we are required to comply with Regulation
M promulgated under the Exchange Act. With certain exceptions, Regulation M precludes us, any affiliated purchasers, and any broker-dealer or other person who participates in such distribution from bidding for or purchasing, or attempting to induce
any person to bid for or purchase, any security which is the subject of the distribution until the entire distribution is complete. Regulation M also restricts bids or purchases made in order to stabilize the price of a security in connection with
the distribution of that security. All of the foregoing may affect the marketability of our securities. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc32717_11"></A>LEGAL
MATTERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The validity and legality of the securities offered hereby and certain other legal matters will be passed upon for the
Company by K&amp;L Gates LLP, Chicago, Illinois and Pittsburgh, Pennsylvania. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc32717_12"></A><A NAME="toc32717_12"></A><A NAME="toc32717_12"></A>EXPERTS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements of <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated and Subsidiaries appearing in <FONT
STYLE="white-space:nowrap">II-VI&#146;s</FONT> Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> dated June&nbsp;29, 2020, and the effectiveness of <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated and Subsidiaries&#146;
internal control over financial reporting as of June&nbsp;30, 2019 (excluding the internal control over financial reporting of CoAdna Holdings, Inc. and Redstone Aerospace Corporation), have been audited by Ernst&nbsp;&amp; Young LLP, independent
registered public accounting firm, as set forth in their reports thereon, which as to the report on the effectiveness of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> internal control over financial reporting contains an explanatory paragraph
describing the above referenced exclusion of CoAdna Holdings, Inc. and Redstone Aerospace Corporation from the scope of such firm&#146;s audit of internal control over financial reporting, included therein, and incorporated herein by reference. Such
consolidated financial statements have been incorporated herein by reference in reliance upon such reports given on the authority of such firm as experts in accounting and auditing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements and schedule of Finisar Corporation as of April&nbsp;28, 2019 and April&nbsp;29, 2018 and for each of
the three years in the period ended April&nbsp;28, 2019, incorporated by reference in this prospectus, have been so incorporated in reliance on the report of BDO USA, LLP, independent registered public accounting firm, incorporated herein by
reference, given on the authority of said firm as experts in auditing and accounting. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc32717_13"></A><A NAME="toc32717_13"></A><A NAME="toc32717_13"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We file annual, quarterly and special reports, proxy statements and other information with the SEC. You can read our SEC filings, including
the registration statement, at the SEC&#146;s website at www.sec.gov. Our web site is located at <FONT STYLE="white-space:nowrap">www.ii-vi.com.</FONT> The information contained on or accessible through our web site is not part of this prospectus.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will provide, upon written or oral request, without charge to you, including any beneficial owner to whom this prospectus is
delivered, a copy of any or all of the documents incorporated herein by reference other than the exhibits to those documents, unless the exhibits are specifically incorporated by reference into the information that this prospectus incorporates. You
should direct a request for copies to us at Attention: Secretary, 375 Saxonburg Boulevard, Saxonburg, Pennsylvania 16056 or you may call us at (724) <FONT STYLE="white-space:nowrap">352-4455.</FONT> </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc32717_14"></A><A NAME="toc32717_14"></A><A NAME="toc32717_14"></A>INCORPORATION BY REFERENCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus &#147;incorporates by reference&#148; certain information that we have filed with the SEC under the Securities Exchange Act of
1934, as amended (the &#147;Exchange Act&#148;). This means we are disclosing important information to you by referring you to those documents. We incorporate by reference the documents listed below and any future filings made by us with the SEC
under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act until the offering is terminated: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/820318/000156459019032471/iivi-10k_20190630.htm">Annual Report on Form
<FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended June&nbsp;30, 2019 filed with the SEC on August&nbsp;16, 2019; </A> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000156459019042658/iivi-10q_20190930.htm">Quarterly
 Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarter ended September&nbsp;30, 2019 filed with the SEC on November&nbsp;12, 2019; </A> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000156459020004069/iivi-10q_20191231.htm">Quarterly
 Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarter ended December&nbsp;31, 2019 filed with the SEC on February&nbsp;10, 2020; </A> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000082031820000006/iivi-20200331.htm">Quarterly
 Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarter ended March&nbsp;30, 2020 filed with the SEC on May&nbsp;11, 2020; </A> </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519189236/d732331d8k.htm">July&nbsp;3,
 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519191239/d768377d8k.htm">July&nbsp;9, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519202673/d778671d8k.htm">July&nbsp;
25, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519209907/d785268d8k.htm">August&nbsp;1, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519219508/d780813d8k.htm">August&nbsp;
13, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519222521/d792454d8k.htm">August&nbsp;15, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519222891/d732685d8k.htm">August&nbsp;
16, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519226885/d786195d8k.htm">August&nbsp;22, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519232444/d767361d8k.htm">August&nbsp;
28, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519248114/d735094d8k.htm">September&nbsp;18, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519250134/d796902d8k.htm">September&nbsp;20,
2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519253049/d808405d8k.htm">September&nbsp;
24, 2019</A> (as amended by the Current Reports on Form <FONT STYLE="white-space:nowrap">8-K/A</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519256345/d766725d8ka.htm">September&nbsp;
27, 2019</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312519309221/d843447d8ka.htm">December&nbsp;
9, 2019</A>), <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519272584/d822502d8k.htm">October&nbsp;23, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519289368/d833112d8k.htm">November&nbsp;
12, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312519304778/d836388d8k.htm">December&nbsp;
3, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312519326612/d862403d8k.htm">December&nbsp;
31, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312520019766/d878420d8k.htm">January&nbsp;
30, 2020</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312520145328/d930712d8k.htm">May&nbsp;
19, 2020</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312520155799/d938285d8k.htm">May&nbsp;
29, 2020</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312520156545/d935912d8k.htm">June&nbsp;
1, 2020</A>, and June 30, 2020 (<A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312520182936/d931566d8k.htm">I</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312520182942/d942419d8k.htm">II
</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312520182949/d53753d8k.htm">III</A>); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the portions of our Definitive Proxy Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519261641/d791789ddef14a.htm">Schedule
 14A</A> filed on October&nbsp;
3, 2019 that are specifically incorporated by reference into our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000156459019032471/iivi-10k_20190630.htm">Form <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the fiscal
year ended June&nbsp;30, 2019; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1094739/000109473919000038/fnsr10kfy19.htm">Audited Consolidated Balance
 Sheets of Finisar as of April&nbsp;28, 2019 and April&nbsp;29, 2018 and the Audited Consolidated Statements of Operations, Comprehensive Income (Loss), Stockholders&#146; Equity and Cash Flows of Finisar for the three years ended April&nbsp;28,
2019, April&nbsp;29, 2018 and April&nbsp;30, 2017, respectively, and related notes (included in Finisar&#146;s Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> for the year ended April&nbsp;28, 2019 filed by Finisar with the
SEC on June&nbsp;14, 2019); </A> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1094739/000109473919000078/fnsr10qq1fy20.htm">Unaudited
 Condensed Consolidated Financial Statements of Finisar as of July&nbsp;28, 2019 (included in Finisar&#146;s Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarter ended July&nbsp;28, 2019 filed by Finisar with the SEC
on September&nbsp;4, 2019); and </A> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The description of the Company&#146;s Common Stock contained in our Registration Statement on Form 8-A filed
pursuant to Section&nbsp;12(b) of the Exchange Act as filed with the SEC on September&nbsp;14, 1987, including any subsequent amendments or reports filed for the purpose of updating such description. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent that any information contained in any report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> or <FONT
STYLE="white-space:nowrap">8-K/A,</FONT> or any exhibit thereto, was furnished to, rather than filed with, the SEC, such information or exhibit is specifically not incorporated by reference. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have authorized no one to provide you with information other than information incorporated by reference or provided in this prospectus. You
should not assume that the information in this prospectus is accurate as of any date other than the date on the front of this document. All documents that we file pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of
this prospectus or after the date of the registration statement of which this prospectus forms a part and prior to the termination of the offering will be deemed to be incorporated in this prospectus by reference and will be a part of this
prospectus from the date of the filing of the document. Any statement contained in a document incorporated or deemed to be incorporated by reference in this prospectus will be deemed to be modified or superseded for purposes of this prospectus to
the extent that a statement contained in this prospectus or in any other subsequently filed document which also is or is deemed to be incorporated by reference in this prospectus modifies or supersedes that statement. Any statement that is modified
or superseded will not constitute a part of this prospectus, except as modified or superseded. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Requests for such copies should be
directed to our Investor Relations department, at the following address: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">375 Saxonburg Boulevard </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Saxonburg,
Pennsylvania 16056 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(724) <FONT STYLE="white-space:nowrap">352-4455</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g32995g11v27.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P><center>
<P STYLE="line-height:3.5pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P></center>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g32717g82q21.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g32717g82q21.jpg
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MAD(Z>EFP-E7AV9P=BHJW.LBW42_9U/AU-D8\YE'V1<%U 4W 1'!$A0LVS N
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M_'(.)LNE[Q:?%3^'^:8OV<R_+):98.L'\(_N3$''^SO>-<]=<3'MP7U]YO\
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5_P"; P_1@V(?U,/_ +DNO_/,?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g32995g11v27.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g32995g11v27.jpg
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MT20Q0567U1514U22D](8)3)A<28T0E9S@;+4UO_$ !T!  (" P$! 0
M       '" D$!08# 0+_Q !6$0 ! P(" PD)"@H(!04    ! @,$  4&$0<2
M(0@3,34W071VLA0B,U%A<W6SM!46&#(T<8&1E+47(U)35%56D]+30F)R@I6A
MH]$D)9*QP3:VP]7P_]H # ,!  (1 Q$ /P">_P &OSI\Y+$WV7O#\J5/X/9O
MZPB_NW:L4^&IA7]BL0?;K=1\&OSI\Y+$WV7O#\J/P>S?UA%_=NT?#4PK^Q6(
M/MUNI;V38GC)*0C5#E54CWKMB=0@"!%#M%U$#'(!O& IS)B8H#V@ AO[:7ZT
MZBU)SSU5*3GX]4D9_P"53/8=#[++P!2'FFW0D\(#B L Y;,P#D<J^*OS7K4N
M]$>D2Y=;F=&>"[3NZ#LB7>6Q<5SEG;A9/W\<1O;J+=9=J9O&[W(K. <%*D</
M$*)1$_[*VMFM3EYFB$TZAE9;<<UW I2<FP"1DG;F<]E+S2?I#A:,,*NXJN%N
ME72.U.AP3%ANLM/%<Q2TI6%O]YJHU"5#A.8RJY3X-?G3YR6)OLO>'Y5UOX/9
MOZPB_NW:C=\-3"O[%8@^W6ZCX-?G3YR6)OLO>'Y4?@]F_K"+^[=H^&IA7]BL
M0?;K=5!N?<126 LUY2PI,R[&?E<6WO<%D2$W&(N&T?*.[??JL%GS-!U^DHMW
M!TA4237^-*40 _;OKB)T14"9)AK6EQ<9Y;*EI!"5%!RU@#M /B-2SPEB)C%N
M&;%B:-'=B1[[:XET9BOJ0MYAN6TEU+3BV^\4M 5DHI[TG@V5Y%6)70UZCA#%
MTAF_,N*L-1,HS@Y3*N0[/QY'3,BBNX813V\)YA MI%Z@V_2%FK-9^1PNDA\:
M=),Q4_'$*R8454V9&AH4E"I+[3"5J!*4EU80%$#:0"<R!MK18HOK.%\-W[$D
MAAR4Q8+/<;P]&94E#TAJW1'9:V6E+[Q+CB6BA"E]Z%$$[*O^^#7YT^<EB;[+
MWA^5=S^#V;^L(O[MVHD?#4PK^Q6(/MUNK]EZ-?G$0\;4IB@!W_J+:EWF#=_U
M$Y>W]?9N_P#?^K[^#V9SW&-^Z=/_ )%?#NU<+\V";^?GN%N'_8&O*\Y]'[SG
MA;#F3<NDS;CV]28SLJX+Y>6M#6W<S26F(RV(Y>7EF\<NZ,= 'B<8T=N$$CD,
M+A1$&Y YBI*Q9N!9L.))E"8P]W,RX\6D-N!2TMI*U!))(UM4$@9;2,AM-;["
MVZYPMB;$ECP\K#%XMAO=SB6MN?)FPG(\9^<\F/'6\AL!>]J?<;0M0(U HK/>
MI-4 UPU2WHHHKV/3WB0,]9MQAA<+LBK'<Y0N^)LF-N>;:N7L7'3,^MU"#(\;
M,SD<J$D9A5C%D%(P"FJ]35,!B$,4<N!%[NFQH>^I9,EU+*75@J2E:^]1F!D3
MK+*4[. JSKF\88A.$\+WS$WN>_=$6*W2+F_!C.(:?>C1$[[*4VMP%"2S&2Z^
M=89%+12,B0:ON-T:_.0;N'4IB@?U[^*U;O+N_JW;C'W_ +=_ZMW_ #W]G;G1
M[,YKC%^EIT?^343ANU<+<^"K^/FGVX_]P*8ST :8I_1WI4QQI[N>YX>\9JR'
M=[N7=PP+1ZRBWQ;JONY+M;E;MI#]+3%JVG$FBPJ=AUT%#D^+,6N_L=N7:;9'
M@..(=6R7B7$ I2K?7W'1D%;=@6 <^<&H:Z6\<1-(V/KUB^#!D6V-=&[6AN'+
M<:=?:,"U0K>LK6S^+.^+BJ<3J\"%)!V@U,RMO2VHHHI5O4#T??,V8\\YMR[%
MZ@<8PT;E3+N2<CQT0_MRZEWT4QOB\IJYVD:]6;AU=9VQ;RB;5RJA\2HLD<Z7
MB"6EG.P++ES9DI,^,A,F5(D)0IMTJ2EYY;@2HC82D* )&S,;*GGA'==X:PWA
M/"^'7\(WR2_8<.V6RO2&9L!+3[MKML:"X\TE??I;=6P5H2OO@E0"MH->1?!K
M\Z?.2Q-]E[P_*L7\'LW]81?W;M=#\-3"O[%8@^W6ZJ%IW#,HUU!2FGNU)EA>
MTZAE]SAR GHI!RWBKIG"7B:RX^2C$%^8[)&R\D"2[$%2]8,T72,=,J@BF'$+
MB*3/5 ;6EY8EF(AQ((2XL/;RE20=NJM6U.>W(C9G4L(F)6',(,8OGQG;7$7A
MU&))<20M"WX$4VX7-YE]:<FR]&8UD.ZIU XA0"BD F^GX-?G3YR6)OLO>'Y5
MV_X/9OZPB_NW:B?\-3"O[%8@^W6ZJZ-H/LQ[]V>\3BZ6O3)MH9!3RC(W9'1Z
M5KQ4S&GBSVFV@7+E1X,L'"L1V6>1*@"':06ZHJ=AB5H+[AQ^Q(C+>DM/]TJ<
M2D-(6G5WL())UN'/7&67B-.31!IPM.E^1?6+98[C:#8F;>\\J=(C/!\7!<M"
M$M"/M26S$45E7#KIRX#58]<Y3PHHHI@_$W1[\T99Q7C3*D=J#Q?$Q^2\?V;D
M!A%/;;NM9Y&,[RMR-N-K'NUD Y"KIDA)$;.%4?BE%4SF3\00KNXN!)DJ-'DI
MGQDID,-/I2IMTJ2EUM+@22-A("LCELS&RHA8@W7V&L/WZ]V%["%]D/62[W*T
M.OM3;>EM]RVS'H:WFTK[Y*'%,E:$J[X)4 =H->@?!K\Z?.2Q-]E[P_*O?\'L
MW]81?W;M:CX:F%?V*Q!]NMU'P:_.GSDL3?9>\/RH_![-_6$7]V[1\-3"O[%8
M@^W6ZG ::U5UT445EG77Y4W+]/S'K%S4:WO"N^<7VC5[L#Y#"Z)&]2BN KSK
M+JZ[8"?*%0?FER;]RC*[# W'R.BR>RFHR[K;D?E]8+'ZU^GHJ=%58T445G"[
M2#O[:O//]DG\1O*0&(N/+KTU_MFKF]"_)/H\ZI67V-NH4UIJ9M2[V?\ WY]'
MGI,X1]HUNUMK#QW:?2$3UR*7FESDLTC=2,4?<TRM)6I!52U1117PR<:PF8V0
MAY5HB_BY5B[C9)BY("C=XP?(*-7C1=,>PZ+ANJHBJ0>PQ#F*/ZZ_*DI6E2%
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MV$M_V^]?_9U-+9V;3+71F+6QIWQEDO4+<UUV+>%\FB[EMUY V0U:RK (.8=
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M1K$JV#64,SD<AMK O&Y;TIV.SW6^3VL/I@V:VSKK,WJ\;X]W);XKLN06FQ%
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M((MFK:&BV[9LW2(BW;MT62":*""*92II(I)E*FDDF4I$R%*0I0*  $CFP A
M   0D  9      ;  . 51I+6MR7*<<6IQQR0\M:UJ*EK6IQ2E+6I1*E*4HDJ
M422222237,U^ZQZ***5=Z3-_W?1=_P"MJ%_^&$J6FD7@L_SS_P#M#J>.XC\)
=I+_L8/[6**51I95/>BBBBBBBBBBBBBBBBBBO_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g32995g36b76.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g32995g36b76.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\
M$0@ 1@"% P$1  (1 0,1 ?_$ !T  0 " P$! 0$           H)"P '" (&
M! 7_Q !'$   !@$" P,%#00(!P     ! @,$!08'  @1$A,)"A0X=WBRMA47
M&B$S-#8Y<G-UM;=!4I?6%A@B,358E=4E,E-5@9+1_\0 '0$  @,! 0$! 0
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M5H9DOM(S42=#;JD)S/#,Y 9G+B:TLPS.>NV&\/W66&^=7.QVFX2=TC0WSB9
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M,BMO6]\LJ=>*5K>:N#*O=9*$8*'$J B0ZRO_ %5/_<W_ -U5LSX3_,TPF0\
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MUP7UM@'IW3QWS9\.6I3J1GT!&0X5F!RNL+=A=IK5]9:TQ<6V>+-4L#2@W*V
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J?PDS</\ Y>,,?ZQ>/]TUWONA7#\@A_U/_P"=!SVEF#_SQQ+\GM?V%?_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
